Call us  Skype: Cre8-Health

Near Hoorn, Contact for Details

Emotional Biology of Cancer

• What is it?
• Why does it exists?
• Where does it come from? Where does it go?

What is my relationship with Cancer:
– • and how can I make friends with it or even love-it-to-health?
– • and how can I become the eternal pupil and learn from it’s teachings?


Cancer is created at the cellular level in the body over 6 specific and interrelated phases.


In PHASE 1 of Cancer

prolonged chronic stress causes stress hormone cortisol levels to skyrocket, depleting all-important adrenaline reserves [essential for healthy cell functioning] and depleting melatonin reserves [essential for healthy immune system functioning].

Phase 1 occurs approximately 18-24 months prior to the diagnosis of cancer. This is where the individual with cancer experiences an “inescapable shock” or acute psycho-emotional trauma, affecting deep sleep and the production of melatonin within the body.

Melatonin is the primary hormone responsible for inhibiting cancer cell growth. Produced by the pineal gland during deep sleep, melatonin inhibits cancer cell growth through the on-going production of interleukin 2 (IL-2), which governs white blood cell immune activity and protects against microbial infection.

Without enough melatonin due to prolonged chronic stress affecting deep sleep patterns, cancer cells thrive. As discovered by Dr Ryke Geerd Hamer (below) every cancer has a different and very specific psycho-emotional cause; whereby a part of the emotional reflex centre in the brain is damaged as a result of the prolonged psycho-emotional trauma. And as each part of the emotional reflex centre in the brain controls and is connected to a different organ of the body, as this emotion centre breaks down experiencing necrosis, so does the organ it controls leading to cancer.

Over the past decades, a number of licensed medical practitioners working in the field of oncology have discovered cancer is preceded by a specific emotional trauma, occurring approximately 2 years prior to the diagnosis of cancer. Two of these practitioners include Dr W Douglas Brodie, founder of the Reno Integrative Medical Center in Nevada, USA and Dr Ryke Geerd Hamer, a German physician and founder of German New Medicine. Both of these practitioners claim to have examined thousands of cancer patients in reaching this conclusion.

More specifically, Dr Ryke Geerd Hamer proposes that each cancer in the body has a different emotional cause which he had identified; in other words the emotional cause for cancer of the left breast is different to that of the right breast and to cancer of the colon, etc. In my own personal experience in treating hundreds of cancer patients to heal the root psycho-emotional cause of their disease, it has been my observation that Dr Ryke Geerd Hamer’s theory that each cancer has a different and very specific psycho-emotional cause is 100% accurate.

For example, I always find a woman presenting with cancer of the left breast has [in line with Dr Hamer’s theory] experienced a psychological and emotional conflict / trauma approximately 2 years prior to the diagnosis of cancer involving the “mother, child or home”. Similarly, I always find a woman presenting with uterine cancer has experienced a “sexual conflict” 2 years prior to the diagnosis of cancer, and so on.

On a personal level, my own mother [who was diagnosed with cancer of the left breast in 1992] experienced a psycho-emotional trauma 2 years prior in 1990 involving the death of her mother, in line with Dr Hamer’s theory. I remember her telling me at the time she felt like a zombie for many months.

As is typical with patients I see, my mother had a tendency to over-react to most difficulties in life and was always highly stressed, and it is this hypersensitivity to life’s stressors that makes one susceptible to cancer. Dr W Douglas Brodie reveals it is not the stressful event that causes cancer, but our inability to cope with life stress.

Dr W Douglas Brodie

Dr W Douglas Brodie

The Cancer Personality,
by Dr W Douglas Brodie:
“In dealing with many thousands of cancer patients over the past 28 years, it has been my observation that there are certain personality traits present in the cancer-susceptible individual.

These traits are as follows:
1. Being highly conscientious, caring, dutiful, responsible, hard-working, and usually of above average intelligence.
2. Exhibits a strong tendency toward carrying other people’s burdens and toward taking on extra obligations, and often “worrying for others.”
3. Having a deep-seated need to make others happy. Being a “people pleaser” with a great need for approval.
4. Often lacking closeness with one or both parents, which sometimes, later in life, results in lack of closeness with spouse or others who would normally be close.
5. Harbours long-suppressed toxic emotions, such as anger, resentment and / or hostility. The cancer-susceptible individual typically internalizes such emotions and has great difficulty expressing them.
6. Reacts adversely to stress, and often becomes unable to cope adequately with such stress. Usually experiences an especially damaging event about 2 years before the onset of detectable cancer. The patient is not able to cope with this traumatic event or series of events, which comes as a “last straw” on top of years of suppressed reactions to stress.
7. Has an inability to resolve deep-seated emotional problems/conflicts, usually beginning in childhood, often even being unaware of their presence.

Typical of the cancer-susceptible personality, as noted above, is the long-standing tendency to suppress “toxic emotions”, particularly anger. Usually beginning in childhood, this individual has held in their hostility and other unacceptable emotions.

More often than not, this feature of the affected personality has its origins in feelings of rejection by one or both parents. Whether these feelings of rejection are justified or not, the individual perceives this rejection as real, and this results in a lack of closeness with the “rejecting” parent, followed later in life by a lack of closeness with spouses and others with whom close relationships would normally develop. Those at the higher risk for cancer tend to develop feelings of loneliness as a result of their having been deprived of affection and acceptance earlier in life, even if this is only their perception. They have a tremendous need for approval and acceptance, and develop a very high sensitivity to the needs of others while suppressing their own emotional needs.

They become the “caretakers” of the world, showing great compassion and caring for others, and will go out of their way to look after others. They are very reluctant to accept help from others, fearing that it may jeopardize their role as the caretaker.

Throughout their childhood they have been typically taught “not to be selfish”, and they take this to heart as a major lifetime objective. All of this is highly commendable in our culture, but must be somehow modified in the case of the cancer patient. A distinction needs to be made here between the “care-giving” and the “care-taking” personality. There is nothing wrong with care-giving, of course, but the problem arises when the susceptible individual derives their entire worth, value and identity from their role as “caretaker”. If this very important shift cannot be made, the patient is stuck in this role, and the susceptibility to cancer greatly increases.

As already stated, a consistent feature of those who are susceptible to cancer appears to be that they “suffer in silence”, and bear their burdens without complaint. These burdens of their own as well as the burdens of others weigh heavily upon these people through a lifetime of emotional suppression. The carefree extrovert, on the other hand, seems to be far less vulnerable to cancer than the caring introvert described above.

How one reacts to stress appears to be a major factor in the larger number of contributing causes of cancer. Most cancer patients have experienced a highly stressful event, usually about 2 years prior to the onset of detectable disease. This traumatic event is often beyond the patient’s control, such as the loss of a loved one, loss of a business, job, home, or some other major disaster.

The typical cancer personality has lost the ability to cope with these extreme events, because his/her coping mechanism lies in his/her ability to control the environment. When this control is lost, the patient has no other way to cope. Major stress causes suppression on the immune system, and does so more overwhelmingly in the cancer-susceptible individual than in others. Thus personal tragedies and excessive levels of stress appear to combine with the underlying personality described above to bring on the immune deficiency which allows cancer to thrive.”

Hamer concentric brain rings
Hamer Herd Concentric Rings —- Look closely for a water ripple effect

Dr Ryke Geerd Hamer: “Every cancer or cancer-like disease originates with a very difficult highly acute, dramatic and isolating shock. The experience of shock is simultaneous or virtually simultaneous on three levels:
1. The Psyche
2. The Brain
3. The Organ.

The development of the conflict determines a specific development of the HH (Hamer Herd) in the brain and of the cancer or cancer-equivalent disease in the organ. There are very specific signs which clearly distinguish the ordinary conflicts and problems in our daily lives. From the very first moment of a DHS (psycho-emotional trauma), you would experience continuous stress on the sympathetic nervous system. The symptoms would include cold hands and/or feet, loss of appetite, weight loss, sleeplessness and dwelling day and night on the conflict content.

This situation will only change when the conflict has been resolved. In contrast to normal everyday problems, we see the patient falling into a lasting stress phase that will cause specific symptoms and a growing cancer.

The HH (Hamer Herd) in the brain, which is immediately visible, shows that the patient’s psyche has very precise, defined symptoms that cannot be overlooked. I discovered the ontogenetic system of tumours and cancer-equivalents after observing about 10,000 cases.

I worked absolutely empirically, like a good scientist should. I documented all the collected cases and the CT scans of the brain with their histological findings. Only after I had put them all together and compared them did I see that there was a system.

I didn’t really occupy myself with this until 1978. I was a doctor of internal medicine and had worked in university clinics for fifteen years, five of them as a professor. Then a terrible thing happened: while asleep on a boat, my son Dirk was shot, for no reason, by a madman, an Italian prince. This was a terrible shock for me, sudden and unexpected, and I was powerless to react.

Every day events or conflicts don’t usually catch us so “off guard”. We generally have a chance to anticipate the normal conflicts that we face in life, but the conflicts we are unable to prepare for and which cause this helplessness and inability to react, create, in essence, a panic shock. We call these biological conflicts.

In 1978 I developed testicular cancer from such a biological conflict, a so-called “loss conflict”. Since I had never been seriously ill, I wondered if my condition had anything to do with the death of my son.

Three years later, as chief of internal medicine in a gynecology-oncology clinic at Munich University, I had the opportunity to study female patients with cancer and to compare my findings to see if their mechanism was the same as mine; if they too had experienced such a terrible shock.

I found that all of them, without exception, had experienced the same type of biological conflict as I had. They were able to recollect the shock, the resulting sleeplessness, weight loss, cold hands and the beginning of tumour growth. There is at present a movement to divide medicine into organic medicine and psychological medicine, or psychotherapy.

When a doctor states that there is no organic cause, he is giving the psychotherapist a free hand to treat these ‘clean’ psychological diseases. Such division is absurd in the eyes of a practitioner of the German New Medicine, because illness cannot be divided and parcelled out. The psyche, brain and organ are three levels of the same organism and the course of events on them is always synchronous.”

Dr Ryke Geerd Hamer

Dr Ryke Geerd Hamer

Dr Ryke Geerd Hamer proposes a person who experiences the onset of detectable cancer has experienced a “biological conflict” or inescapable shock that causes subsequent organ-necrosis and tumour cell growth.

Below is a list of conflicts Dr Ryke Geerd Hamer proposes serves as the trigger event and cause for each different type of cancer in the body:

ADRENAL CORTEX: Wrong Direction. Gone Astray
BLADDER: Ugly Conflict. Dirty Tricks
BONE: Lack of Self Worth. Inferiority Feeling
BRAIN TUMOUR: Stubbornness. Refusing to Change Old Patterns. Mental Frustration
[Dr Hamer does not propose a conflict for brain tumour. The above is Louise Hay’s proposed cause.] BREAST MILK GLAND: Involving Care or Disharmony
BREAST MILK DUCT: Separation Conflict
BREAST LEFT: Conflict concerning Child, Home or Mother
BREAST RIGHT: Conflict with Partner or Others
BRONCHIOLES: Territorial Conflict
CERVIX: Severe Frustration
COLON: Ugly Indigestible Conflict
GALL BLADDER: Rivalry Conflict
HEART: Perpetual Conflict
INTESTINES: Indigestible Chunk of Anger
KIDNEYS: Not wanting to Live. Water or Fluid Conflict
LARYNX: Conflict of Fear and Fright
LIVER: Fear of Starvation
LUNGS: Fear of Dying or Suffocation, including Fear for Someone Else
LYMPH GLANDS: Loss of Self-Worth
MELANOMA: Feeling Dirty, Soiled, Defiled
MIDDLE EAR: Not being able to get some Vital Information
MOUTH: Cannot Chew It or Hold It
OESOPHAGUS: Cannot Have It or Swallow It
PANCREAS: Anxiety-Anger Conflict with Family Members. Inheritance
PROSTATE: Ugly Conflict with Sexual Connotations
RECTUM: Fear of Being Useless
SKIN: Loss of Integrity
SPLEEN: Shock of being Physically/Emotionally Wounded
STOMACH: Indigestible Anger. Swallowed Too Much
THYROID: Feeling Powerless
TUMOUR: Nursing Old Hurts and Shocks. Building Remorse
[Dr Hamer does not propose a conflict for tumour. The above is Louise Hay’s proposed cause.] UTERUS: Sexual Conflict

The conflicts for some other diseases are as follows:
Diabetes and hypoglycemia: A right-handed female develops hypoglycemia from anxiety and revulsion, if left-handed she develops insulin-dependent diabetes. A right-handed male develops insulin-diabetes from a conflict of resisting or struggling against something, if left-handed he develops hypoglycemia.
Heart infarct: fight for territory or its content.
Haemorrhoids: both, a right-handed woman with an identity conflict and also a left-handed man with territorial anger in the healing phase will get haemorrhoids.
Multiple sclerosis and Paralysis: inability to escape or continue on or to hold on to or not knowing what to do.
Facial paralysis: fear of losing face, having been made a laughing stock.
Psoriasis involves separation conflict concerning mother, father, family, home, friends or pets.
Psychoses of all kinds have one or more active Hamer Herds in each of the two parts of the brain.
Vitiligo, Leukoderma: ugly or brutal separation conflict.

Studies below show a correlation between extreme suppression of emotions (primarily anger) and a highly stressful life event preceding the onset and development of cancer.

1. Extreme suppression of anger was the most commonly identified characteristic of 160 breast cancer patients who were given a detailed psychological interview and self-administered questionnaire in a study conducted by the King’s College Hospital in London, as reported by the Journal of Psychosomatic Research. “Patients results are based on statistical comparisons between 69 patients found at operation to have breast cancer and a control group comprising the remaining 91 patients with benign breast disease.

Our principle finding was a significant association between the diagnosis of breast cancer and a behaviour pattern, persisting throughout adult life, of abnormal release of emotions. This abnormality was, in most cases, extreme suppression of anger and, in patients over 40, extreme suppression of other feelings.”



2. In a study conducted over 4.5 years by the Cancer Centre of the Greek Social Security Department in Athens, researchers found a traumatic life event typically preceded the onset of cancer. “The authors present their results as far as psychological stress influences the development of cancer of the breast in 813 patients (Group A) and in 685 women who did not have cancer of the breast (Group B).

They were able to show that Group A had a positive correlation which was statistically very significant with the following parameters: the death of a much-loved person; the negative behaviour of the husband; an unexpected change in life style; continual conflicts in the family; financial problems; unsatisfactory sex life; consultations with a psychiatrist and allergy.

The authors conclude that they believe that it is useful to look at all the factors that are known as risks for cancer of the breast, including the influence of psycho-traumatic factors.”



3. The University of Helsinki, Finland conducted a study of 10,808 women to discover whether stressful life events preceded the onset of cancer. “Independently of total life events, – divorce/separation, death of a husband, and death of a close relative or friend were all associated with increased risk of breast cancer. The findings suggest a role for life events in breast cancer etiology through hormonal or other mechanisms.”



4. Madelon Visintainer, now Associate Professor at Yale University School of Medicine, found rats receiving mild shock they could not escape from had a significantly higher rate of tumour progression. “Rats experienced inescapable, escapable, or no electric shock 1 day after being implanted with a Walker 256 tumour preparation. Only 27% of the rats receiving inescapable shock rejected (cleared) the tumour, whereas 63 percent of the rats receiving escapable shock and 54 percent of the rats receiving no shock rejected the tumour. These results imply that lack of control over stressors reduces tumour rejection and decreases survival.”



5. Retired Clinical Professor of Surgery at Yale Medical School, Dr Bernie Siegel: “I have collected 57 extremely well documented so-called cancer miracles. At a certain particular moment in time they decided that the anger and the depression were probably not the best way to go, since they had such little time left. And so they went from being that to being loving, caring, no longer angry, no longer depressed, and able to talk to the people they loved. These 57 people had the same pattern. They gave up, totally, their anger, and they gave up, totally, their depression, by specifically a decision to do so. And at that point the tumours started to shrink.”


Studies below show expressing and releasing toxic negative emotions (such as anger, hate, resentment, grief) increases the survival rates of cancer patients significantly.

1. The Ontario Cancer Institute conducted a ground-breaking study to evaluate the effects of psychological self-help work, principally the expression of negative emotions, on the survival time of 22 medically incurable metastatic cancer patients. With an expected 1 year survival rate, median survival was 2.25 times that predicted by the oncology panel, with an incredible 6 of the 22 patients still alive after five years. “Twenty-two patients with medically incurable metastatic cancer of various kinds received weekly group psycho-therapy for up to 1 year, the great majority remaining well enough to attend the group for at least 8 months.

The intervention had three components.

The first was support: patients were comforted and strengthened by the group in the face of life-threatening disease. Expression and clarification of feelings was encouraged, as was rational problem solving, frank communication with important others, monitoring and changing of cognition’s and the daily application of coping skills. Patients were helped to become, as Spiegel (1986) put it, ‘experts in living’. Fear of death and dying was openly discussed and group members who died were grieved for.

The second aspect of the intervention was homework: there was an emphasis on taking responsibility, not for one’s cancer or its outcome, but for the implementation of a personal program of self-help. Patients were asked to practice coping skills, such as relaxation and meditation, and to completed 20 weekly sessions of written homework, which included questions and assignments over a wide range of psychological and spiritual / existential issues (examples: What makes me feel I really want to live? Which people are important in my life, and how much support do I feel each of them gives me? Draw a picture of an important aspect of your life at the following (specified) stages. Attend at least one community spiritual or religious meeting and write about how it affected you).

The third facet of the intervention was group psychotherapy: patients’ entrenched opinions and habit patterns were explored and modifications suggested; e.g. common issues included guilt, denial, blaming physicians and others, exaggerated dependencies, feelings of helplessness and a perceived loss of entitlement to longer life. Median survival of the 22 subjects was 2.25 times that predicted by the oncology panel (with six subjects still alive at the time of writing).”



2. The California Department of Health Services in association with the National Cancer Institute studied 847 women with breast cancer from 1985-1994 and found those who reported low levels of emotional expression had a fourfold risk of dying from cancer than those who reported high levels of emotional expression. Study findings: “The survival analysis was conducted with a sample of 847 women, 442 (52.2 percent) of whom were Black and 405 (47.8 percent) of whom were White.

Expression of emotion was related to better survival (hazard ratio (HR) = 0.6; 95 percent confidence interval (CI): 0.4, 0.9), and suppression of emotion was associated with worse survival (HR = 1.4; 95 percent CI: 1.1, 1.9). Patients had a nearly fourfold risk of dying from breast cancer if they reported low levels of both emotional expression and emotional support when compared with patients with early stage tumours who reported high levels of both. These results suggest that the opportunity for emotional expression may help improve survival among patients with invasive breast cancer.”



3. The California Breast Cancer Research Program conducted a follow-up study of Dr. David Spiegel’s 1989 study and found the survival rate of women in his group therapy program who openly expressed their anger was doubled (3.7 years), compared to the women in his group therapy program who constrained their anger (1.8 years), with 6 of the 50 women who openly expressed their anger still living at 7 years post-entry study. Study findings: “In our preliminary results (H = 28 with 69 tape-by-woman segments in the data set), long moments of indirect or constrained anger during the first few months of group therapy strongly predicted an earlier death (p < .01).

By 3 years from study entry, all but 2 women with more constrained anger have died–compared with 6 women, who express no constrained anger or only express short moments of it, still living at 7 years post-study entry. The mean survival time was, thus, doubled for women who do not constrain anger (3.7 years compared with 1.8). This is the first behavioural study in a relatively naturalistic setting which links bottling up anger with shorter survival.”

4. The UCLA School of Medicine found psychological intervention significantly increased cancer survival rates in malignant melanoma patients. Six years after the study, only 3 of the 34 patients given psychological intervention had died, compared to 10 of 34 patients in the control group not given psychological intervention.

Study findings: “We evaluated recurrence and survival for 68 patients with malignant melanoma who participated in a 6-week structured psychiatric group intervention 5 to 6 years earlier, shortly after their diagnosis and initial surgical treatment. For control patients, there was a trend for recurrence (13/34) and a statistically significant greater rate of death (10/34) than for experimental patients (7/34 and 3/34, respectively).”



5. The University of Rochester and Harvard School of Public Health followed 729 individuals over 12 years and found a 70% increase in cancer deaths for those who were scored at above the 75% level of suppressing emotions. “Emotion suppression at the 75th vs. 25th percentile conveyed a significant elevation in risk (HR = 1.35, or a 35% increase) of death from any cause.

This was comparable to the increase in mortality risk observed for 3.1 years of life expectancy. The same difference in suppression was associated with a 70% increase in risk (HR = 1.70) of death from cancer (a 5.6 year difference in life expectancy). Our analysis of a US nationally representative sample, followed for 12 years for mortality by cause of death, revealed significant associations between higher levels of emotion suppression and all-cause as well as cancer-related mortality.”



Q-Link E/M stress protection

Q-Link E/M stress protection

While most people cope with stress with relative ease, those susceptible to cancer appear to be highly vulnerable to life’s stresses and traumas, and feel unable to cope when life throws a curve-ball their way.

These people are perfectionists and live in fear of conflict, stress and loss and are deeply frightened of negative events. And when faced with a highly stressful or traumatic event they have not anticipated, which inevitably happens during their life, react adversely and are unable to cope. They experience “inescapable shock” and feel trapped and unable to escape from the painful feelings [of anger, hate, resentment and/or grief] associated with the traumatic experience.

Stress hormone cortisol levels skyrocket and remain at high levels. High stress levels generally mean a person cannot sleep well and cannot produce enough melatonin which is produced during deep sleep usually between the hours of 1am and 3am in the morning.

Melatonin is the primary hormone responsible for regulating the immune system, and when there is not enough melatonin, production of IL-1 (Interleukin 1) and IL-2 (Interleukin 2) is diminished. Interleukin 1 protects against infection and Interleukin 2 regulates the activities of white blood cells [including T cells, B cells, neutrophils, macrophages and natural killer cells] responsible for immunity.

When there is insufficient levels of Interleukin 2, stress-induced viral-bacterial-yeast-like-fungus that have pleomorphised in the body [in Phase 3 of Cancer: The Cancer Fungus] are now free to invade normal cells; damaging cell DNA through the release of “mycotoxins” within the cell nucleus, causing proto-oncogenes to mutate into oncogenes, and inhibiting tumor suppressor genes [notably p53] which results in normal cells mutating into cancer cells.

Within the 1st Phase of Cancer the following sequence of events can be observed in the cancer patient:

Read More…
Phase 1 of emotional Cancer

Phase 1 of emotional Cancer

In PHASE 2 of Cancer

depleted adrenaline reserves breaks the cell’s oxygen Krebs Cycle causing a build-up of lactic acid in the cell.

During phase 2, elevated stress hormone cortisol levels deplete all-important adrenaline (epinephrine) levels in the adrenal glands.

There are limited reserves of adrenaline in the body and when a person is under constant psycho-emotional stress these reserves are depleted quickly. While insulin is used to transport glucose into cells, it is adrenaline which is critical for cell respiration and for converting this glucose in the cell into ATP energy for the body and for healthy cell division [which occurs via the metabolic pathway known as Oxidative Phosphorylation and via the Krebs’ Citric Acid Cycle of the mitochondria of the cell].

Without adrenaline to stimulate the G-Protein to stimulate production of the GDP molecule [which is essential for mitochondrial cell respiration and glucose conversion] the cells Krebs’ Citric Acid Cycle and Oxidative Phosphorylation metabolic pathway is broken and the cell is forced to ferment glucose instead as a means to obtain [smaller amounts of] ATP energy [via the process known as Glycolysis], which creates lactic acid in the cell and a low pH environment.

This sets the stage for the cancer-fungus to evolve in phase 3 to ferment rising glucose and lactic acid, causing cell mutation.

Fungus take over of cells

Fungus take over of cells

In 1931 Otto Warburg was awarded the Nobel Prize for Physiology in discovering the mechanism for mitochondrial cell respiration. As director of the Kaiser Wilhelm Institute for Biology in Germany, he is most famous for discovering that cells mutate into cancer cells due to loss of respiration within the cell’s mitochondria, which results in the cell fermenting glucose as a secondary means to obtain energy for the body and the cell [through the process known as Glycolysis]. This process of fermenting glucose occurs in the cytosol (or intracellular fluid) of the cell, causing a discharge of lactic acid. The discharge of lactic acid within the cell creates a low pH (or highly acidic) environment.

Otto Warburg postulated the cause of the loss of cell respiration was—sounding most logical—a depletion of oxygen in the cell. And while this may play a role, it is in fact the depletion of adrenaline that disrupts cell respiration above all. When a person is under prolonged psycho-emotional stress, adrenaline levels initially spike; yet over months and years adrenal fatigue results and the production of adrenaline declines significantly. This is important, as it is the job of adrenaline to convert glucose within cells into ATP energy for general bodily use and for cell respiration. This occurs through adrenaline stimulating the G-Protein which subsequently stimulates production of the GDP molecule within cells.

The Krebs’ Citric Acid Cycle [which is akin to a large processing factory inside the mitochondria of the cell] uses the GDP molecule to produce the energy molecule GTP. GTP is used to convert glucose into ATP energy through the metabolic pathway known as Oxidative Phosphorylation. In cancer patients, the Krebs’ Citric Acid Cycle [which is the precursor to Oxidative Phosphorylation] comes to a halt without the all-important GDP molecule to keep the glucose-ATP-processing factory running, causing a build-up of glucose in the cell.

In order to survive, the cell ferments glucose instead to obtain ATP energy, discharging lactic acid. The somatid (tiny micro-organisms necessary for life that live in our body) pleomorphise into pathogenic (harmful) cancer-fungus to ferment rising glucose and lactic acid in the body’s cells, migrating to the cell nucleus in phase 3 of cancer, causing cell mutation and cancer.

Good Krebs Cycle

Good Krebs Cycle

Bad Krebs Cycle

Bad Krebs Cycle

Otto Warburg: “Summarized in a few words, the prime cause of cancer is the replacement of the respiration of oxygen in normal body cells by a fermentation of sugar (glucose). All normal body cells meet their energy needs by respiration of oxygen, whereas cancer cells meet their energy needs in great part by fermentation. All normal body cells are thus obligate aerobes [that grow only in the presence of oxygen], whereas all cancer cells are partial anaerobes [that don’t need oxygen to grow]. From the standpoint of the physics and chemistry of life this difference between normal and cancer cells is so great that one can scarcely picture a greater difference.

Oxygen gas, the donor of energy in plants and animals is dethroned in the cancer cells and replaced by an energy yielding reaction of the lowest living [microbial] forms, namely, a fermentation of glucose. Cancer cells originate from normal body cells in two phases.

The first phase is the irreversible injuring of [cell] respiration. The irreversible injuring of respiration is followed, as the second phase of cancer formation, by a long struggle for existence by the injured cells to maintain their structure, in which a part of the cells [the mitochondria] perish from lack of energy, while another part succeed in replacing the irretrievably lost respiration energy by fermentation energy.

Since the respiration of all cancer cells is damaged, our first question is, How can the respiration of body cells be injured? One method for the destruction of the respiration of body cells is removal of oxygen. If, for example, embryonal tissue is exposed to an oxygen deficiency for some hours and then is placed in oxygen again, 50 percent or more of the respiration is usually destroyed. The cause of this destruction of respiration is lack of [GTP and ATP] energy. As a matter of fact, the cells need their respiratory energy to preserve their structure, and if respiration is inhibited, both [mitochondrial] structure and [cell] respiration disappear.

Another method for destroying [cell] respiration is to use respiratory poisons. From the standpoint of energy, this method comes to the same result as the first method. No matter whether oxygen is withdrawn from the cell or whether the oxygen is prevented from reacting by a poison, the result is the same in both cases – namely, impairment of respiration from lack of [GTP/ATP] energy. When the respiration of body cells has been irreversibly damaged, cancer cells by no means immediately result. For cancer formation there is necessary not only an irreversible damaging of the respiration but also an increase in the fermentation.

The driving force of the increase of fermentation, however, its the [GTP/ATP] energy deficiency under which the cells operate after destruction of their respiration, which forces the cells to replace the irretrievably lost respiration energy in some way. They are able to do this by a selective process that makes use of the fermentation of the normal body cells.

The more weakly fermenting body cells perish, but the more strongly fermenting ones remain alive, and this selective process continues until the respiratory failure is compensated for energetically by the increase in fermentation. Only then has a cancer cell resulted from the normal body cell. Now we understand why the increase in fermentation takes such a long time and why it is possible only with the help of many cell divisions. Since the increase in fermentation in the development of cancer cells takes place gradually, there must be a transitional phase between normal body cells and fully formed cancer cells.

Thus, for example, when fermentation has become so great that de-differentiation has commenced, but not so great that the respiratory defect has been fully compensated for energetically by fermentation, we may have cells which indeed look like cancer cells but are still energetically insufficient. Such cells, which are clinically not cancer cells, have lately been found, not only in the prostate, but also in the lungs, kidney, and stomach of elderly persons. Such cells have been referred to as “sleeping cancer cells”. Figure 4 [below] shows that the pathways of respiration and fermentation are common as far as pyruvic acid. Then the pathways diverge. The end products of [glucose] fermentation are reached by one single reaction, the reduction of pyruvic acid by dihydro-nicotinamide to lactic acid. On the other hand, the end products of the oxidation of pyruvic acid, H2O (water) and CO2 (carbon dioxide) [of respiration], are only reached after many additional reactions.”

Figure 4

Figure 4

Otto Warburg

Dr Waltraut Fryda served as a senior physician at the world-famous Issels’ Ringberg Klinik in Germany. She wrote the book Diagnosis: Cancer, underscoring adrenaline depletion as the central causal component of cancer that destabilized the homeostasis of the body’s correct tissue pH balance.

Dr Fryda used adrenaline and the administration of the positive form of lactic acid [dextrorotatory lactic acid] to normalize the body’s correct [acid-alkaline] pH balance and to restore health to many patients. In the excerpt from her book below she describes this mechanism.

Dr Waltraut Fryda

Dr Waltraut Fryda

Dr Waltraut Fryda: “A cancer patient always suffers from over-acidification of the tissues. In order to deprive the tumour of a favourable environment, the tissue-pH value must be changed from acid to alkaline. This is easier said than done because all alkaline-forming nutrition loses its intended effect soon after entering the bloodstream, as it is used up in the blood for buffering, before it can reach the tissue. The [human bodily] organism always endeavours via appropriate regulating mechanisms to maintain the blood-pH value at around 7.4, which is absolutely essential for the stability of hormones, in particular adrenaline.

A brief recapitulation of the law of reversed proportionality of pH value changes in blood and tissue: if the blood-pH value drops, the tissue-pH value rises (and vice versa). This gives us a kind of lever: it should be possible to indirectly raise an unhealthy acid-tissue-pH value by lowering the slightly alkaline blood-pH value. Over-acidification of tissue is prevented in a healthy [human] organism by the dextrorotatory lactic acid that is constantly produced by movement and suitable nutrition. This, therefore, indicates that an input of optically dextrorotatory lactic acid is needed.

This may seem like a contradiction to the layman, in that tissue is to be deacidified by administering an acid. The paradox disappears, however, if all interrelations are kept in mind. Acidification of the blood by means of dextrorotatory lactic acid (commercially available as ‘Pleo Sanuvis Drops 4X, 6X, 12X, 30X, 200X’) lowers the blood-pH value until it and the tissue-pH value reach the same level. This takes precisely five weeks in cancer patients who are administered an appropriate dose of dextrorotatory lactic acid [thirty drops, three times daily].

This has been confirmed time and again by my own measurements over many years of the blood-pH value. During the period from the first until approximately the fourth day in week 6, the acid substances will be discharged from the tissue into the blood, the pH value of which drops for a short time to very low values. The excretion of the pathological substances of the tissue via blood, liver, kidneys, and skin during this period is apparent from an entirely pungent and acid smell.

I am as yet unable to explain the reasons for the period of five weeks. However, the same physical and psychological symptoms occur after this [five week period]. Feeling generally unwell, the patient is irritable, aggressive, and depressed at the same time. At the height of this “changeover reaction”, usually lasting for three days, the pH value of tissue and blood reach the same level.
The continued supply of dextrorotatory lactic acid (Pleo Sanuvis) finally ensures an unproblematic and physiological restitution and maintenance of a blood-pH value of 7.4 and a tissue-pH value above that figure.

This will remove a critical precondition for continued growth of a tumour in a cancer patient, namely the acid environment. Kidneys and liver are now capable of carrying out their full detoxification functions, thereby, laying the foundations for a safe removal of subsequently occurring disintegration products of a malignant tumour. Finally, dextrorotatory lactic acid also causes the biological neutralization of the toxic, levorotatory lactic acid of the tumour into a non-toxic, racemic form. This is of utmost importance, as it removes the stimulus for an increase in the cell division rate. Normalizing the acid-alkali balance also stimulates adrenaline production and improves its effectiveness, an equally important precondition for a healthy [aerobic cell] metabolism.

The therapy here introduced offers relatively great advantages to patients, because, the “changeover” reaction over three days excepted, they are not subjected to any stress. It is neither painful nor does it cause vomiting, loss of appetite, bleeding of the bladder, or other similar side effects that are well-known from aggressive therapies.” [Note: Dextrorotatory lactic acid is a main ingredient in whey (the liquid component of cottage cheese) that is combined with flaxseed oil to form the world’s leading anti-cancer diet, known as the Johanna Budwig Cancer Diet.]

Studies below show a direct correlation between glucose fermentation, tumour growth and increased lactic acid production within the cell environment.

1. In a study conducted by the Department of Hematology and Oncology, University of Regensburg, Germany, researchers found glucose fermenting tumor cells produce high levels of lactic acid which suppress immune system T cell production and activity. “A characteristic feature of tumors is high production of lactic acid due to enhanced glycolysis.

Here, we show a positive correlation between lactate serum levels and tumor burden in cancer patients and examine the influence of lactic acid on immune functions in vitro. Lactic acid suppressed the proliferation and cytokine production of human cytotoxic T lymphocytes (CTLs) up to 95% and led to a 50% decrease in cytotoxic activity. A 24-hour recovery period in lactic acid-free medium restored CTL (T cell) function.



2. In a study conducted by the Department of Radiology, University of Pennsylvania, Philadelphia, researchers found when the immune-suppressant drug rapamycin was used to inhibit lactic acid production in lymphoma cancer cells, the expression of the key enzyme hexokinase II found in glycolysis (glucose fermentation) was also inhibited. “Using human B-cell lymphoma models and MRS (magnetic resonance spectroscopy imaging), we have demonstrated that the inhibition of the mTOR signaling pathway can be detected in malignant cells in vitro and non-invasively in vivo [in animal models] by the measurement of lactate levels. An mTOR inhibitor, rapamycin, suppressed lactic acid production in lymphoma cell line cultures and also diminished steady-state lactate levels in xenotransplants (cell tissue transplants).

In xenotransplants, 2 days of rapamycin treatment produced significant changes in lactic acid concentration in the tumor measured in vivo, which were followed by tumour growth arrest and tumor volume regression. The rapamycin-induced changes in lactate (lactic acid) production were strongly correlated with the inhibition of expression of hexokinase II, the key enzyme in the glycolytic (glucose fermentation) pathway.”



3. In a study conducted by the Institute for Physical Chemistry, University of Düsseldorf, Germany, researchers found tumor cells deprived of oxygen and then fed glucose produced five times more lactic acid than normal tumor cells. “Viability, glycolytic capacity and energy metabolism under anaerobic conditions were studied in the hepatoma (liver tumor) cell lines HTC, FU5 and HepG2 and in rat and human hepatocytes using glucose and fructose as glycolytic precursors.

During 6 hours of anaerobic incubation without additional substrate, [cell] viability decreased rapidly in FU5 and HTC cells, whereas viability of HepG2 cells was not significantly affected. In all tumor cells, 10 mmol/L glucose prevented hypoxic (deprived oxygen) cell injury almost completely. Lactate formation from glucose was about five times higher than in hepatocytes (liver cells) under these circumstances.”



4. In a study conducted by the Marseilles Cancer Research Centre, The National Health and Medical Research Institute, France, researchers found hypoxia (the deprivation of oxygen) increased the rate of glycolysis (glucose fermentation) in pancreatic cancer cells, causing them to switch from mitochondrial respiration to lactic acid production.

“Here, using a well-defined mouse model of pancreatic cancer, we report that hypoxic areas from pancreatic ductal adenocarcinoma are mainly composed of epithelial cells harboring epithelial-mesenchymal transition (invasion) features and expressing glycolytic markers, two characteristics associated with tumor aggressiveness. We also show that hypoxia (deprivation of oxygen) increases the “glycolytic” switch of pancreatic cancer cells from oxydative phosphorylation to lactate (lactic acid) production and we demonstrate that increased lactate efflux (lactic acid release) from hypoxic cancer cells favors the growth of normoxic (normal oxygen level) cancer cells.”



5. In a landmark study conducted by the Department of Medicine, Case Western Reserve University, Cleveland, Ohio, researchers found in normal cells [stimulated by oxalyl chloride to ferment more glucose], the excess glucose not needed for normal cell-controlled metabolism was near-completely converted to lactic acid. “In this study we examined the metabolic fate of glucose in cells in which glucose transport is stimulated by exposure to CoCl(2) (oxalyl chloride), an agent that stimulates the expression of a set of hypoxia-responsive genes [genes that respond well to deprived oxygen states] including several glycolytic enzymes and the Glut-1 glucose transporter.

In cells treated with CoCl(2), the net increase in glucose taken up was accounted for by its near-complete conversion to lactate (lactic acid). Cells stably transfected to overexpress Glut-1 also exhibited enhanced net uptake of glucose with the near-complete conversion of the increased glucose taken up to lactate; however, the effect in these cells was observed in the absence of any change in the activity of two glycolytic enzymes examined. These findings suggest that in cells in which glucose transport is rate-limiting (controlled) for glucose metabolism, enhancement of the glucose entry step per se results in a near-complete conversion of the extra glucose to lactate.”



With the 2nd Phase of Cancer the following sequence of events can be observed in the cancer patient:

Read More…
Phase 2 of emotional Cancer

Phase 2 of emotional Cancer

In PHASE 3 of Cancer

the somatid (a tiny microorganism in the body necessary for life) pleomorphises (changes) into the cancer-fungus to ferment (remove) the build-up of lactic acid, causing cell nucleus DNA mutations.

During phase 3, somatids (tiny microorganisms necessary for life) that live in our body pleomorphise [or change] into yeast-like-fungus to ferment excess glucose and lactic acid in cells.

In a healthy person, somatids are limited to 3 stages in their life cycle – somatid, spore, double spore. However, in a highly acidic (low pH) lactic acid environment caused by prolonged chronic stress breaking the cell’s Krebs’ Citric Acid Cycle, somatids pleomorphise into a further 13 stages. These stages include viral-bacterial-yeast-like-fungus forms which then migrate to the cell nucleus to reproduce, releasing acidic waste products called “mycotoxins”, inhibiting cell DNA repair and inhibiting the all-important tumour suppressor genes.

Without the tumour suppressor genes [namely p53] to regulate cell death (apoptosis) when the cell has mutated beyond repair, the cell lives on and ‘cell-growth regulating’ proto-oncogenes turn into oncogenes, causing normal cells to mutate into cancer cells.
Bacterial Cancer Yeast Fungus

Over the past few centuries leading microbiologists from all over the world have discovered a tiny microorganism necessary for life that underpins all life, including all stem cell and viral-bacterial growth. This tiny microorganism has been given many names including the Somatid, the Microzyma, the Bione, the Sanal/P-Microcell/Granule, the Protit and the Turquoise Blue Granule.

These “somatids” are so small they appear invisible under normal microscopic lens, and require high magnification equipment to see their naturally active moving state. A common feature of these somatid life forms, observed uniformly, is their ability to pleomorphise (change) into viral-bacterial-yeast-like-fungus forms under low pH acidic conditions.

Microbiologists who have identified these somatid life forms include Antoine Béchamp [Professor of Chemistry at the University of Strasbourg]; Arthur Isaac Kendall PhD [Director of Medical Research, Northwestern University Medical School Chicago]; Royal Raymond Rife PhD [inventor of the high-magnification Rife Microscope]; Edward C Rosenow, Sr [who served as Director of Experimental Biology for the Mayo Clinic between 1915 and 1944]; Bong-Han Kim [medical surgeon at Pyongyang Medical University and Kyung-Rak Institute who is widely recognized to have discovered the primo-vascular system]; Kwang-Sup Soh [professor at the Biomedical Physics Laboratory, School of Physics, Seoul National University, South Korea]; Wilhelm Reich [Deputy Director of the Vienna Ambulatorium, Sigmund Freud’s psychoanalytic outpatient clinic]; and Professor Gunther [zoologist], amongst many others.

The most recent of these academics to discover the existence of this living organism is Professor Gaston Naessens of France who coined the term “somatid” to describe these small bodies. Professor Naessens found when cell tissue is healthy, [these somatids that live in the tissue and blood as well as the intracellular cytosol of the cell] are limited to 3 stages
—– somatid, spore, and double spore;

however when the cell environment is acidic and the immune system impaired, these tiny microorganisms pleomorphise into a further 13 viral-bacterial-yeast-like-fungus stages to ferment excess glucose and lactic acid, causing cancer. These fungal pathogenic forms migrate to the cell nucleus to reproduce, releasing acidic waste products called “mycotoxins”, inhibiting cell DNA repair and inhibiting the all-important tumor suppressor genes.

Without tumor suppressor genes [namely p53] to regulate cell death (apoptosis) when the cell has mutated beyond repair, the cell lives on and ‘cell-growth-regulating’ proto-oncogenes turn into oncogenes, causing normal cells to mutate into cancer cells. While Professor Naessens observed these viral-bacterial-yeast-like-fungus forms were the cause of cancer within the body, he is not however the first to have observed the connection between cancer and these microbes.

In 1890 William Russell [pathologist in the School of Medicine at the Royal Infirmary in Edinburgh] found parasitic yeast-like fungus organisms within all forms of cancer he examined, which ranged from barely visible to “half again as large as a red blood corpuscle”.

In 1901, Harvey Gaylord of New York State Pathological Laboratory of the University of Buffalo confirmed Russell’s research, finding small to large parasitic forms in every cancer he examined and published a report in the American Journal of the Medical Sciences titled “The Protozoon of Cancer”.

In the 1920s, James Young [an obstetrician from Scotland] was able to grow pleomorphic viral-bacterial stages from various cancers which he found had a specific life cycle and spore stages.

In 1925, John Nuzum [pathologist and physician at the University of Illinois, College of Medicine] isolated pleomorphic virus-like bacteria from 38 of 41 early stage breast cancers and was able to induce breast cancer in 2 or 5 dogs injected with these microbes.

In 1932, Royal Raymond Rife [granted an honorary Doctor of Parasitology by the University of Heidelberg Germany for his work in making all the photo-micrographs for the “Atlas of Parasites”] cultured a viral-bacterial microorganism from a human breast cancer which he injected into 412 healthy rats which all developed breast cancer without fail. He subsequently found this microbe morphed into various viral-bacterial-yeast-like-fungus forms.

In the 1940-1950s, Virginia Livingston [first female resident physician at a New York hospital, assigned to study bacterial infection], microbiologist Eleanor Alexander Jackson PhD [awarded the A. Cressy Morrison Prize by the New York Academy of Sciences for discovering certain forms of tubercle bacteria] and Irene Diller of the National Cancer Institute Fox Chase Cancer Center, Philadelphia collaborated together after each independently observing the microbe in cancer.

After culturing the viral-bacterial microbe from human breast cancer tissue and re-injecting it into mice, they found the incidence of cancer doubled. Since then mainstream medicine has discovered the human papilloma virus (HPV) to be the cause of cervical cancer and head, neck and throat cancer; helicobacter pylori c. bacteria to be the cause of stomach cancer; hepatitis B and C virus to be the cause of liver cancer; and schistosoma haematobium (bilharziasis) bacteria to cause bladder cancer.

Professor Gaston Naessens

Professor Gaston Naessens

Professor Gaston Naessens: “A somatid is a basic living particle. It is indispensable for life. Without it, cellular division can’t take place. It is polymorphic [meaning it can grow from one form to another, from a virus to a bacterium to a fungus].

We were able to grow it in a culture and that’s where we observed its polymorphism in two cycles. First there is a micro-cycle during which the reproductive hormone that permits cellular division is developed. This [healthy 3 stage] cycle is stopped by inhibitors in the blood and during certain illnesses, including degenerative diseases.

This micro-cycle, in 3 stages keeps going and becomes a 16 stage cycle [during illness]. In 1949 when I was working in haematology I had the feeling I wasn’t seeing everything there was to see in blood. I saw something moving, but I didn’t know what it was. I concentrated on the problem of light wave-lengths.

That’s how I perfected a system that gave me very worthwhile results and which enabled me to develop a microscope that allows us to see this famous particle. Little by little I was able to observe it and I extracted it from the blood. I was able to isolate it and grow it in a culture and that’s how I established its polymorphism.”

Professor Gaston Naessens continued: “For more than a century the traditional method of examining blood has consisted of smearing it onto a slide, fixing it and staining it, to determine the tinctorial affinities (properties) of the elements it contains.



On the left [above] we can see blood prepared according to this method. We can identify the red corpuscles, white corpuscles and platelets. This is dead blood.

On the right we are seeing blood through a somatoscope. This is living blood examined within 10 minutes after it was drawn. We can see red corpuscles, white corpuscles, platelets and somatids, which we couldn’t see on the fixed slide. In the course of this [somatid] micro-cycle, a growth hormone is formed that is indispensable for cellular division.

This phenomenon has been observed repeatedly in in-vitro cultures. If under the effects of stress or for that matter any biological stressor the blood’s [immune] inhibitors are diminished to any considerable degree, the somatids’ micro-cycle evolves into a cycle that is both different and polymorphic. We then see the appearance of the various stages of a macro-cycle – 13 additional stages in all [seen in the diagram below].

Phases of polymorphism

Phases of polymorphism

First we notice a bacterial form that is the normal evolution of the micro-cycle [in stage 4] where the inhibitors have been diminished.

This endogenous bacterial form has been observed by many researchers. The double bacteria which evolves [in stage 5] from the preceding bacterial form is often observed in blood smears. Its particularity is the ability to divide itself by scissiparity to form rods. The rod form [stage 6] looks like a bacterial form expect that it is longer and its cytoplasm seems empty.

It should be noted this [next] bacterial form [in stage 7] possesses two terminal spores. The granulated double-spore bacterial form [seen in stage 8] has a cytoplasm filled with granulations that begin to move. The maturation of the granulated double-spore bacterial form [in stage 9] results in a mycobacteria well-known to microbiologists.

The cytoplasm is also self-developing. The myco-bacteria that we have just seen [in stage 10] has developed further and formed bubble-like enclaves to which it owes its name: bubble-mycobacteria. Here we see the bursting of the bubble-mycobacteria [in stage 11] and the release of its elements of its cytoplasm into the medium.

The yeast-like formations that result [in stage 12] from the bursting of the bubble-mycobacteria, have a diameter of 4-5 microns. The yeast-like formations proliferate and become ascospore forms [in stage 13], pre-cursors of mycelial elements.

From an asci form we can observe the formation of a phallus [in stage 14] in which the cytoplasm gradually takes shape to constitute the young mycelial form. It is through a conjuncture and with peristaltic movements that the young mycelial form develops a phallic cytoplasm and eventually becomes an adult mycelia form [in stage 15]. When this mycelial form element reaches full maturity [in stage 16] its cytoplasm is extremely active and when it bursts it releases an enormous quantity of new [somatid] particles into the medium, each [new] particle capable of duplicating the entire cycle.”

Professor Gaston Naessens continued: “For more than a century the traditional method of examining blood has consisted of smearing it onto a slide, fixing it and staining it, to determine the tinctorial affinities (properties) of the elements it contains.

Antoine Béchamp, who replaced Louise Pasteur as Professor of Chemistry at the University of Stasbourg, was among the first to discover the somatid [which he called the microzyma]. Béchamp demonstrated in his experiments that the somatid evolves into viral-bacterial-yeast-like-fungus forms out of a natural programmed response to a disturbed cellular environment, to ferment either excess glucose or excess carbonic acid or lactic acid.

And this is important for the cancer patient, as during prolonged chronic stress the Krebs’ Citric Acid Cycle is broken and glucose and lactic acid levels rise sharply within the cell causing the somatid to pleomorphise into causing-causing viral-bacterial-yeast-like-fungus.

In a landmark year-long experiment below, Béchamp demonstrated that the somatid remains only in the viral-bacterial-yeast-like-fungus state up until all lactic acid and most glucose is fermented and thus removed from the organism. At that point the viral-bacterial-yeast-like-fungus forms disappear, devolving back into the somatid.

Antoine Béchamp

Antoine Béchamp

Antoine Béchamp: “The cellularists, regarding the cellule (cell) as the simplest anatomical element, believed that it proceeded necessarily from a former cell, holding it to be the vital unit, and regarded an organism as the sum of these units.

We now know that that was a deduction from incomplete and superficial observations, for the cellule, a transitory anatomical element, has the microzyma (somatid) for its anatomical element. It is this which alone possesses all the characteristics of an anatomical element, and which must be regarded as the unit of life. It is what I have already stated in the following terms: “The microzyma (somatid) is at the beginning and at the end of every living organization.

It is the fundamental anatomical element whereby the cellules, the tissues, the organs – the whole organism – can be defined as living.” The living being, filled with microzymas (somatids), carries in itself the elements essential for life, disease, death and destruction. This is because the cause of our diseased condition is always within ourselves.

The microzymas (somatids) are organized ferments, and they can under favourable [highly acidic and immune deficient] conditions produce bacteria. Under other circumstances they become builder of cellules. All organisms are created by them. In short, the cellule, the bacterium itself, can re-become a microzyma (somatid), and thus the microzymas (somatids) are seen to be the beginning and end of all organization.

The state of perfect health results from the constancy and regularity of the coordinated functioning of the organs within which the microzymas (somatids) are healthy. And it will thus be understood that the microzymas (somatids), whether of certain cellules (cells), the vitellus (embryo), or the blood, also realize after their manner the conditions of this constancy and regularity.

When these conditions are no longer realized, they may undergo vibrionian (curved rod-like bacterial) evolution [as seen in stage 6 above]. We must remember that any microzyma (somatid), before it accomplishes the evolution which produces a bacterium, passes through the evolutionary phases of microzyma (somatid) slightly changed in form, of microzyma (somatid) successively associated in twos, in threes, in several grains, etc; [this being the 3 stage somatid micro-cycle – somatid, spore, double spore].

This determined, let us take some fresh [beer] yeast and steep it in from three to four times its weight of creosated distilled water to destroy the influence of germs of the air. In this situation, at about 30°C and without any trace of air, it will for a long time disengage pure carbonic acid [and alcohol and ascetic acid], preserving its form all the time. Evidently it has only been able to produce all these things at the expense of its own substance, of its contents, since its tegument (outer covering) at first remains whole. And if the process of alteration is allowed to continue, this tegument itself will disappear, and its microzymas (somatids) will become free and vibrios (curved rod-like bacterium) will appear.

The phenomenon of the spontaneous destruction of the cellules (cells) of beer yeast has enabled me to confirm the generality of the fact which I had long before observed in studying the microzymian (somatid) origin of the vibrioniens (curved rod-like bacterium).

While the [cell] globule of yeast is being destroyed and its microzymas (somatids) set free and begin to undergo vibrionian (curved rod-like bacterium) evolution, several phases of this evolution are to be observed, which [Professor] Estor and I have described from the commencement of our researches upon the liver, etc, namely, at first the microzymas (somatids) are scarcely altered in their size and form; then microzymas (somatids) of from 3 to 10 and 20 grains, all of the same size; then vibrios (curved rod-like bacteria) properly so-called; then bacteria often very large, motile (moving) or not; also the amylobacters (corkscrew bacteria), either free or fastened end to end.

All of these productions may be seen at the same time in the field of the microscope. Now if without changing any of the conditions of the experiment the observation of it is continued, it will be seen that all the [viral-bacterial-yeast-like-fungus] forms other than the single microzymas (somatids) disappear successively; for the amylobacters (corkscrew bacteria) disappear; then new forms of smaller dimensions appear and disappear in turn, so that in the end there remain only swarms of motile (moving) forms scarcely differing from the original microzymas (somatids) which had evolved.

Speaking then in the language of anatomy, we may say that the microzymas (somatids) become vibrioniens (rod-like bacteria) by evolution; the vibrios, the bacteria, the vibrioniens (viral-bacterial-yeast-like-fungus) in general, return to the microzymas (somatids) form by an inverse phenomenon of evolution.

I recall the facts that [Professor] Ester and I, in our note, described an experiment from which we concluded that in the presence of pure calcic carbonate [which subsequently produces carbonic acid in the presence of glucose-starch], and for so long as the microzymas of the fibrin (somatids of the somatid-spore) continued to evolve, they behaved as alcoholic ferment, and as ascetic, lactic and butyric ferments.

The proportions of the materials employed [for this experiment] were as follows: fecula (glucose-starch) of potatoes, 5 parts, transformed into [glucose] starch in 85 per cent of water, pure calcic carbonate, 1 part; and fibrin (somatid-spores), fresh, moist, newly prepared 0.13 parts. The temperature of the oven was 35° to 40° C. The two experiments [which are two phases of the same year long experiment] were started on the 22nd of May.

The next day, disengagement of gas commenced: a mixture of carbonic acid and of hydrogen. One of the experiments [the first] was stopped on the 10th of September for the purpose of making the analysis. There was still a large amount of fecula (glucose) not transformed. The products of the fermentation were: absolute alcohol (21cc), propionic acid (12g), butyric acid (150g), crystallised acetate of soda (650g) [and most importantly] crystallised lactate [acid] of chalk (709g).

The second operation [of the year long experiment] was continued until the lactate [acid] formed had been [completely] transformed [by the bacterial-yeast-like-fungus]; [and] analysis of the products was made on the 10th of May of the following year. There was still some fecula (glucose) not transformed [and no presence remaining of lactate acid].

Thus, as in the classical lactic fermentations, the ferment which produced the lactic acid is also that which destroys this acid. I shall, by and by, insist further on the fact that the bacteria (yeast-like-fungus) of the microzymas (somatid) which evolve in the first [part of the experiment to ferment the glucose & lactic acid] have gradually but completely disappeared in the second [part of the experiment] so that at the end there only remained a few forms closely allied to the microzymas (somatids).” [Excerpts from the book ‘The Blood and its Third Element’ by A. Béchamp]

Put simply: If you can get rid of the toxic emotions that cause the lactic acid in your cells, the cancer-fungus will devolve back into the healthy harmless somatid, having no more lactic acid to ferment.

Studies below show the link between increased lactic acid fermentation in the cell and cancer:

1. In a study conducted by the Department of Hematology and Oncology, University of Regensburg, Germany, researchers found significantly high production of lactic acid in tumors which suppressed immune system T cell function. “A characteristic feature of tumors is high production of lactic acid due to enhanced glycolysis.

Here, we show a positive correlation between lactate serum levels and tumor burden in cancer patients and examine the influence of lactic acid on immune functions in vitro. Lactic acid suppressed the proliferation and cytokine production of human cytotoxic T lymphocytes (CTLs) up to 95% and led to a 50% decrease in cytotoxic activity. A 24-hour recovery period in lactic acid-free medium restored CTL (T cell) function.”


2. In a study conducted by the Institute of Developmental Biology and Cancer, National Centre for Scientific Research, University of Nice, France, researchers found malignant tumors have high levels of lactic acid due to glucose fermentation (glycolysis) and that blocking the protein that transports lactic acid for use within the tumor significantly suppressed glycolysis, lactic acid utilization and tumor cell growth. “Malignant tumors exhibit increased dependence on glycolysis, resulting in abundant export of lactic acid, a hypothesized key step in tumorigenesis. Lactic acid is mainly transported by two H(+)/lactate symporters, MCT1/MCT4, that require the ancillary protein CD147/Basigin for their functionality.

First, we showed that blocking [lactic acid transporter] MCT1/2 in Ras-transformed [tumor] fibroblasts with AR-C155858 suppressed lactate export, glycolysis, and tumor growth. Second, in the human colon adenocarcinoma cell line (LS174T), we showed that combined silencing of [lactic acid transporter] MCT1/MCT4 via inducible shRNA, or silencing of [its required protein] CD147/Basigin alone, significantly reduced glycolytic flux (glucose fermentation) and tumor growth. Collectively, these findings highlight that the major protumoral action of CD147/Basigin is to control the energetics of glycolytic tumors via [lactic acid transporter] MCT1/MCT4 activity and that blocking lactic acid export provides an efficient anticancer strategy.”


3. In a landmark study conducted by the Department of Stem Cell Biology & Regenerative Medicine, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, researchers found lactic acid stimulated tumor cell metastasis 10-fold. “Here, we directly evaluate whether the end-products of aerobic glycolysis (3-hydroxy-butyrate and L-lactate [lactic-acid]) can stimulate tumor growth and metastasis, using MDA-MB-231 breast cancer xenografts as a model system. More specifically, we show that administration of 3-hydroxy-butyrate [acid] (a ketone body) increases tumor growth by ∼2.5-fold, without any measurable increases in tumor vascularization/angiogenesis.

Both 3-hydroxy-butyrate [acid] and L-lactate (lactic acid) functioned as chemo-attractants, stimulating the migration of epithelial cancer cells. Although L-lactate (lactic acid) did not increase primary tumor growth, it stimulated the formation of lung metastases by ∼10-fold.

Thus, we conclude that ketones and lactate (lactic acid) fuel tumor growth and metastasis, providing functional evidence to support the “Reverse Warburg Effect”.”

4. In a study conducted by the Institute for Clinical Chemistry and Laboratory Medicine, University Hospital of Regensburg, Germany, researchers found blocking the protein CD147 required for MCT1 and MCT4 lactic acid transport and utilization reduced the proliferation of pancreatic cancer cell lines. “MCT1 and MCT4 are the natural transporters of lactate (lactic acid), and MiaPaCa2 [pancreatic cancer] cells exhibited a high rate of lactate (lactic acid) production, which is characteristic for the Warburg effect, an early hallmark of cancer that confers a significant growth advantage.

CD147 [protein] is required for the function and expression of monocarboxylate [lactate] transporters MCT1 and MCT4 that are expressed in human PDAC [pancreatic cancer] cells. Silencing of CD147 [lactic acid transporter protein] by RNA interference (RNAi) reduced the proliferation rate of MiaPaCa2 and Panc1 cells.”

5. In a study conducted by the Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Japan, researchers found blocking the protein CD147 required for MCT1 and MCT4 lactic acid transport and utilization significantly decreased proliferation, invasiveness and production of tumor growth factor VEGF in malignant melanoma cancers. “Cancer cells require glycolysis for energy; this results in excessive lactate (lactic acid) production and secretion. Lactate, the end product of glycolysis, reduces the extracellular pH and contributes to the proliferation, invasiveness, metastasis, and angiogenesis of tumor cells.

Our previous results revealed that the over-expressed CD147/basigin (lactic acid transporter protein) plays a critical role in malignant melanoma (MM) invasiveness, metastasis and angiogenesis. In the present study, we investigated whether CD147/basigin is involved, via its association with MCT1 and 4 to transport lactate, in glycolysis and then contributes to the progression of A375 melanoma cells. A375 cells expressed remarkably higher CD147, MCT1 and 4 and showed increased glycolysis rate compared with normal human melanocytes (NHMC). Furthermore, silencing of CD147/basigin in A375 cells by a siRNA clearly abrogated the expression of [lactic acid transporter] MCT1 and 4 and their co-localization with CD147/basigin and dramatically decreased the glycolysis rate, extracellular pH, and the production of ATP.

Thus, cell proliferation, invasiveness, and VEGF production were significantly decreased by siRNA [blocking CD147 lactic acid transporter protein]. These results strongly suggest that highly-expressed CD147 [protein] interacts with [lactic acid transporter] MCT1 and 4 to promote tumor cell glycolysis, resulting in the progression of MM (malignant melanoma).”

6. In a study conducted by the Dept. of Molecular Genetics, Osaka Medical Center for Cancer and Cardio-vascular Diseases, Japan, researchers found lactic acid in tumor cells enhances IL-23 protein production which promotes tumor development. “IL-23 is a proinflammatory cytokine consisting of a p19 subunit and a p40 subunit that is shared with IL-12. IL-23 is overexpressed in and around tumor tissues, where it induces local inflammation and promotes tumor development.

Many tumor cells produce large amounts of lactic acid by altering their glucose metabolism. In this study, we show that lactic acid secreted by tumor cells enhances the transcription of IL-23p19 and IL-23 production in monocytes/macrophages and in tumor-infiltrating immune cells that are stimulated with TLR2 and 4 ligands.

These results suggest that rather than just being a terminal metabolite, lactic acid is a proinflammatory mediator that is secreted by tumor cells to activate the IL-23/IL-17 proinflammatory pathway but not the Th1 pathway. Targeting the lactic acid-induced proinflammatory response may be a useful approach for treating cancer.”

7. In a study conducted by the Department of Hematology and Oncology, University of Regensburg, Germany, researchers found even low concentrations of lactic acid in white blood cells significantly suppressed the tumor necrosis factor (TNF) responsible for: regulation of immune system function, cell death when the cell has mutated beyond repair, and prevention of normal cells mutating into cancer cells. “To study the impact of LA (lactic acid) on TNF secretion, human LPS-stimulated monocytes (white blood cells) were cultured with or without LA (lactic acid).

TNF (tumor necrosis factor) secretion was significantly suppressed by [even] low concentrations of LA (lactic acid< or = 10 mM).

These results support the hypothesis that TNF (tumor necrosis factor) secretion by [immune system] human monocytes (white blood cells) depends on glycolysis and suggest that LA (lactic acid) and acidification may be involved in the suppression of TNF secretion in the tumor environment.”

8. In a study conducted by the Institute of Clinical and Experimental Research, Université catholique de Louvain Belgium, researchers found lactic acid activates HIF-1 via the lactic acid transporter MCT1, which triggers tumor growth in vivo. “The transcription factor hypoxia-inducible factor-1 (HIF-1) is a key contributor to glycolysis (glucose fermentation).

We report that lactate (lactic acid), the end-product of glycolysis, inhibits prolylhydroxylase 2 activity and activates HIF-1 in normoxic oxidative (normal oxygen) tumor cells. Lactate (lactic acid) activates HIF-1 and triggers tumor angiogenesis and tumor growth in vivo, an activity that we found to be under the specific upstream control of the lactate (lactic acid) transporter monocarboxylate transporter 1 (MCT1) expressed in tumor cells.”



In 1983, the Holy Spirit of God revealed in the following transcript what we know as cancer is in fact seven different types of fungus. God was asked whether the following information from Spirit is valid: {“For the greatest bane of all, the cancer, here to you I give the answer – ketone.

For the prevention of cancer, use the mind, but to reassure yourself in the mortal mind take three teaspoons of vinegar once a day, anytime, any day. For the cure of the ravage (cancer), the destruction of pain, take three teaspoons a day (of vinegar), three times any time, any way”. And he asks the question: “How soon will the cure be detected?” – ” From one day to the next, but there will be complete and total remission of all traces of the disease within three days.” And he asks: “How does this work?” And it responded: “For every action, there is a reaction.

You should know this from your friend and mine, – A. Einstein. The disease is an action of a mould-type fungus. The acidic acid reacts against this fungus by reversal of the growth tissues it has fed upon. It literally starves to death. Since it must feed constantly, the destruction of this fungus is quick.”}

The Holy Spirit of God: “This Awareness indicates that this is valid in most cases, to a degree. This Awareness indicates that most of what is called cancer is in fact a fungus.
This Awareness indicates it appears there are approximately seven different types of fungus which are diagnosed as cancer.

This Awareness indicates that the use of vinegar as that which, (this particularly apple cider vinegar), has been effective in the treatment and the remission of many of these types of fungus.

This Awareness indicates that it will depend on the stage of the condition and the general immunity system of the individual, whether the individual has the recuperative powers to recover with the assistance of the vinegar.

This Awareness indicates also high doses of Vitamin C, the use of lemon and other anti-oxidants as has been given by this Awareness in past readings. These also are of great benefit in countering these fungus types.

This Awareness indicates that there are many types of cancer, and many causes, and much of this is a psychological condition, caused by free radicals within the system that have an effect upon the metabolism, creating a dissolving of the immunity system to allow these fungi, and other elements to grow in a destructive manner within the tissue.

This Awareness indicates there are many ways whereby cancer can be cured. There are many ways whereby cancer can remain incurable, depending largely on the type and the progression of the cancer.

This Awareness indicates that this does however appear to be reaching a time wherein even though much vested interest prevents a single publicized common cure for all types of cancer, there are still increasing numbers of entities being cured from cancer, wherein the past, many of these would have died.” [Note: Apple cider vinegar damages tooth enamel. Therefore always dilute ACV in a large glass of water.]


Within the 3rd Phase of Cancer the following sequence of events can be observed in the cancer patient:

Read More…

Phase 3 of emotional Cancer

Phase 3 of emotional Cancer

In PHASE 4 of cancer,
depleted adrenaline reserves means niacin and NAD can no longer be synthesized in the body, further breaking the cell’s oxygen Krebs Cycle.

During phase 4, depleted adrenaline (epinephrine) levels cause a depletion of dopamine in the brain. Adrenaline is made by dopamine, and as more and more dopamine is used up during prolonged chronic stress, the amino-acid tryptophan creates serotonin to offset depressed mood.

This results in a depletion of tryptophan which is needed to synthesize niacin / niacinamide (vitamin B3) for cell respiration. Normally tryptophan converts niacin / niacinamide into NAD coenzymes which are then used by the Krebs’ Citric Acid Cycle in the mitochondria of the cell for cell respiration, glucose conversion and the creation of ATP energy.

Without niacin and NAD coenzymes, the Krebs’s Citric Acid Cycle / Oxidative Phosphorylation metabolic pathway is broken, causing the cell to ferment glucose instead for energy, resulting in cell mutation and the formation of cancer.

Krebs citric acid cycle

Krebs citric acid cycle

In the 1950’s, Dr Abram Hoffer, Director of Research at the Regina Psychiatric Services Branch, Dept. of Public Health, Canada, while administering high doses of oral vitamin C and niacin (vitamin B3) to patients hospitalized with psychiatric disorders, accidently found this combined treatment of vitamin C and niacin also effected a cure in a number of psychiatric patients with incurable cancer.
Dr Hoffer subsequently went on to treat cancer patients in his own private practice from 1967 to 2005 and found the principle treatment of vitamin C and niacin in late stage cancer patients, whether undertaking chemotherapy, radiation or not, resulted in a life extension increase of 5.7 months [in the control group of 33 patients who did not follow his program] to 100 months on average [for the remaining 101 patients who did follow his program].

Hoffer was particularly focused on the health properties of niacin—and for good reason—for niacin is crucial to the Krebs’ Citric Acid Cycle, and in turn to the optimal functioning of the metabolic pathway Oxidative Phosphorylation.

Niacin and niacinamide (also known as nicotinamide) are both forms of vitamin B3 and are synthesized [in the liver] from the amino acid tryptophan into coenzymes called NAD for the Krebs’ Citric Acid Cycle to convert glucose into ATP energy for the cell and for the body. If this critical glucose-converting-ATP-energy-producing factory is shut down, then the cell is forced to ferment glucose instead via the process known as Glycolysis to obtain smaller amounts of ATP energy.

This in turn creates a highly acidic low pH environment and the somatid [as mentioned in phase 3] pleomorphises within the body into viral-bacterial-yeast-like-fungus to ferment rising glucose levels in cells, causing normal cells to mutate into cancer cells.

In cancer patients we see a chronic niacin deficiency caused by a chronic tryptophan deficiency. It takes 60mg of tryptophan for the liver to synthesize 1mg of niacin in the body, and when tryptophan is depleted so too is niacin. Tryptophan becomes depleted in the body when a person experiences prolonged psycho-emotional stress, as a result of stress depleting all-important adrenaline reserves. Adrenaline is made by dopamine, and as more and more dopamine is used up during stress, the amino-acid tryptophan synthesizes serotonin to offset depressed mood.

This subsequently results in a depletion of serotonin and tryptophan, meaning niacin and niacinamide can no longer be created or converted by tryptophan into NAD coenzymes for the Krebs’ Citric Acid Cycle for healthy cell functioning.

Krebs citric acid cycle cancer

Krebs citric acid cycle cancer

Krebs citric acid cycle normal

Krebs citric acid cycle normal

Dr Abram Hoffer [Clinical Procedures in Treating Terminally Ill Cancer Patients with Vitamin C + Niacin]: “I recall that in 1952 when I was working as a resident in psychiatry at the Munroe Wing which was a part of the General Hospital in Regina, a woman who had her breast removed for cancer was admitted to our ward. She was psychotic. This poor lady had developed a huge ulcerated lesion, she wasn’t healing, and she was in a toxic delirium.

Her psychiatrist decided that he would give her shock treatment, which was the only treatment available at that time. I decided I would like to give her vitamin C instead. As director of research, I had the option of going to the physicians and asking them if I could do this with their patients. A friend of mine was her doctor and he said, “Yes, you can have her.” He said, “I’ll withhold shock treatment for three days.”

I had thought that I would give her three grams per day, which was our usual dose at that time, for a period of weeks, but when he told me I could have three days only, I decided that this would not do. Therefore, I decided to give her one gram every hour.

I instructed the nurses that she was to be given a gram per hour except when she was sleeping. When she awakened, she would get the vitamin C that she had missed. We started her on a Saturday morning and when her doctor came back on Monday morning to start shock treatment she was mentally normal.

I wanted to know, if vitamin C would have any therapeutic effect. To our amazement her lesion on her breast began to heal. She was discharged, mentally well, still having cancer and she died six months later from her cancer. This was an interesting observation which I had made at that time and which I had never forgotten.

There was another root to this interest. In 1959, we found that the majority of schizophrenic patients excreted in their urine a factor that we call the mauve factor, which we have since identified as kryptopyrrole. I was looking for a good source of this urinary factor. We had thought that the majority of schizophrenics had it.

We thought that normal people did not have it but I was interested in determining how many people who were stressed also had the factor. Therefore, I ran a study of patients from the University Hospital who were on the physical wards. They had all sorts of physical conditions including cancer, I found to my amazement that half the people with lung cancer also excreted the same factor.

1960, a very famous gentleman of Saskatchewan, one of the professors retired and was admitted to the psychiatric department at our hospital. He was psychotic. He had been diagnosed as having a bronchiogenic carcinoma. It had been biopsied and was visualized in the x-ray and it had also been seen in the bronchoscope. While they were deciding what to do, he became psychotic so they concluded that he had secondaries in his brain.

Because he became psychotic, he was no longer operable and instead they gave him cobalt radiation. It didn’t help the psychosis any. He was admitted to our ward where he stayed for about two months, completely psychotic. He was placed on the terminal list, I discovered that he was on our ward, so I thought he may have some mauve factor in his urine. On analysis he revealed huge quantities.

I had discovered by then that if we gave large amounts of B3 (Niacin) along with vitamin C to these patients, regardless of their diagnosis, they tended to do very well. He was started on three grams per day each of nicotinic acid (niacin) and ascorbic acid on a Friday. On Monday he was found to be normal. A few days later I said to him, “You understand that you have cancer?” He said, “Yes, I know that.” He was friendly with me because I had treated his wife for alcoholism some time before.

I said to him, “If you will agree to take these two vitamins as long as you live, I will provide them for you at no charge. In 1960, I was the only doctor in Canada that had access to large quantities of vitamin C and niacin. They were distributed through our hospital dispensary. He agreed. That meant he had to come to my office every month in order to pick up two bottles of vitamins. I didn’t know that it might help his cancer.

I was interested only in his psychological state. However, to my amazement he didn’t die. After 12 months, I was having lunch with the director of the cancer clinic, a friend of mine, and I said to him, “What do you think about this man?” And he said, “We can’t understand it, we can’t see the tumor any more.” I thought he’d say, “Well, isn’t that great.” So I asked, “Well, what’s your reaction?” He responded, “We are beginning to think we made the wrong diagnosis.” The patient died, 30 months after I first saw him, of a coronary.

Here’s another case that is very interesting. A couple of years later, a mother I had treated for depression came back to see me. Once more she was depressed. She said she had a daughter 16, who had just been diagnosed as having an osteogenic sarcoma of the arm. Her surgeon had recommended that the arm be amputated. She was very depressed over this and so I asked her, “Do you think you can persuade your surgeon not to amputate the arm right away?” And I told her the story about the man with the lung cancer.

She brought her daughter in and I started her on niacinamide, 3 grams per day, plus vitamin C, three grams per day. She made a complete recovery and is still well, not having had to have surgery. But this time I concluded that maybe B-3 (niacin) was the therapeutic factor. The reason for that, of course, is very simple. I liked B3 and I didn’t have much interest in vitamin C.

When I moved to Victoria, another strange event happened. In 1979, a woman developed jaundice and during surgery a six centimetre in diameter lump in the head of the pancreas was found. They were too frightened to do a biopsy, which apparently is quite standard. They thought that the biopsy might disseminate the tumor. The surgeon closed and told her to write her will.

They said she might have three to six months at the most. She was a very tough lady and she had read Norman Cousins’ book Anatomy of an Illness. So she said to her doctor, “To hell with that, I’m not going to die.” And she began to take vitamin C on her own, 12 grams per day. When her doctor discovered what she was doing, he asked her to come and see me, because by that time I was identified as a doctor who liked to work with vitamins.

I started her on 40 grams of vitamin C per day, to which I added niacin, zinc and a multivitamin, multi-mineral preparation. I had her change her diet by staying away from high protein and fat. I didn’t hear from her again for about six months. One Sunday, she called me. Normally when I get a call from a patient on a Sunday, it’s bad news.

She immediately said, “Dr Hoffer, good news! I asked, “What’s happened?” She said, “They have just done a CT scan and they can’t see the tumor,” So then she said, “They couldn’t believe it. They thought the machine had gone wrong; so they did it all over again. And it was also negative the second time.” She had her last CT scan in 1984, no mass, and she is still alive and well today.

The last case I’m going to give details of one born in 1908. His mother died of cancer and his father had a coronary at the age of 80. My patient had had a myocardial infarction in 1969, and again in 1977, followed by a coronary bypass. In March on 1978, he suddenly developed pain in his left groin and down the left leg. In February 1979, he developed a bulge in his left groin, and later, severe pain with movement.

In surgery, a large mass infiltrating sarcoma was found, part of which was removed, but a mass the size of a grapefruit was left. The tumor was eroding into a ramus of the pubic bone. They concluded that it was not radio-sensitive. In March he had palliative radiation to his left half – 4500 rads. The pain was gone at the end of the radiation. On May 28, he developed a severe staph infection, and in June he was very depressed because his wife was dying of cancer and also he was suffering from drainage of chronic infection.

In July he still had a purulent discharge in two areas. Now the mass was visible and palpable in the left iliac area above the inguinal ligaments. In January of 1980, he saw me for the first time. I started him on 12 grams of vitamin C per day and I recommended to his referring doctor that he give him IV ascorbic acid, 2.5 grams, twice per week, which he agreed to. I gave him niacin, vitamin B6 and zinc to balance it out. In April, the mass began to regress and the oncologist wrote, “This is interesting, it must be something else.” In other words, the patient said, the vitamin C is helping and the oncologist said, no it isn’t.

The oncologist put a note in the file, “He’s probably responding to chemotherapy.” But he had never had chemotherapy. The infection was gone. In May 1980, his x-ray showed reconstruction of the left superior pubic ramus. In July he wrote to me telling how grateful he was to be so well. In February of 1988, he went back to the cancer clinic for some recurrent facial skin carcinoma. He died in the fall of 1989 of coronary disease when he was 81. This man survived 10 years after having been diagnosed with cancer.

I examined every cancer patient referred to me between July 1978 and April 1988 and followed them to January 1990. I did not miss a single case. A total of 134 were seen. And I dated the time that they first saw me as day zero. The only thing I wanted to look at was survival. I wanted hard data, something that couldn’t be argued within. I wasn’t going to say the patients were better or not better because these are subjective terms. These 134 fell into two groups. It wasn’t my fault that this happened because I treated every one of them exactly the same way.

I did not plan a double blind prospective study. What I planned and what I did was to advise every patient what I thought they ought to do in terms of their cancer. If they were getting radiation, I suggested they stay with it. If they were getting chemotherapy, I suggested they stay with that. I never advised them about their surgery, chemotherapy or radiation. However, out of these 134, there were 33 who did not or could not follow the program. For example, on chemotherapy, they were so nauseated that they couldn’t hold anything down and if they couldn’t hold the vitamins down they weren’t going to do very much good. There were some who didn’t believe in the program. [Note: Dr Hoffer and Linus Pauling revised this number in official literature to 132 patients and 31 not following the program. See the full study]
The other 101 did stay on their program at least two months. Some went off in the third or fourth month but they stayed on it for at least two months. I was encouraged by Linus Pauling. I followed them all. First of all, I contacted their doctors. I contacted the patients that were still alive. I contacted their families. I got all their records from the cancer clinics. I had a complete file on every patient I had seen so that I knew within a matter of months exactly what had happened to them.

The results were analysed by Dr. Linus Pauling using a new technique for analyzing cohorts. The data is as follows: 33 [later 31] controls – they survived an average of 5.7 months, from the first day that I saw them. There were two treatment cohorts: a cohort of 40 females with cancer of the breast, ovary, uterus or cervix. The second cohort of 61 were other types of cancer. The cohorts were divided into two groups. First were the poor responders, those who didn’t do well (20% of patients); they survived an average of 10 months, nearly twice as long as the control. The others, the good responders (80% of patients), were divided into two groups.

The female group survived an average of 122 months and the other group 72 months. I think this is very significant. There was a tremendous difference in the survival rate. Today, all the controls are dead, 50% of the treated group are still alive. Over the past year, I did another survey and of the remainder only three more have died. It cannot be all due to cancer because I’m dealing with a population with ages between 60 and 80. They are going to die of other causes as well. This was published in the Journal of Orthomolecular Medicine, Volume 5, p. 143, 1990.

Abram hoffer

Abram hoffer

Dr Abram Hoffer founded the International Society for Orthomolecular Medicine and his cancer treatment protocol (outlined in step 8 of the below 12 Step Cancer Survivor Program) was endorsed by founding father of vitamin c therapy, Linus Pauling who stated: “For many years Dr. Hoffer has prescribed for his psychiatric patients large amounts of vitamin C, usually 12 grams per day, a good amount of niacin, 1.5 or 3 grams per day, and mega-amounts of several other vitamins and certain minerals.

Those patients with various kinds of cancer who followed his regimen, in addition, for some of them, to receiving conventional therapy, have survived far longer, on the average about 16 times as long, years rather than months. I now recommend strongly that cancer patients follow the regimen prescribed by Dr. Hoffer, rather than just taking megadoses of vitamin c.”

Within the 4th Phase of Cancer the following sequence of events can be observed in the cancer patient:

Read More…

Phase 4 of emotional Cancer

Phase 4 of emotional Cancer

In PHASE 5 of cancer,
depleted adrenaline reserves causes a depletion of Vitamin C reserves, causing cell mitochondrial DNA mutations.

During phase 5, depleted adrenaline levels (caused by prolonged chronic stress) cause a depletion of ascorbic acid (vitamin C) in the adrenal glands. Ascorbic acid is the key ingredient used by dopamine to make noradrenaline (norepinephrine) in the adrenal glands, which is then converted to adrenaline.

During prolonged chronic stress more and more adrenaline is pumped out and then depleted, meaning more and more ascorbic acid is used up in the creation of adrenaline. During chronic stress the adrenal glands also release ascorbic acid into the body to diminish the stressful impact of adrenaline [and other stress hormones] on the heart and blood pressure systems.

Ascorbic acid is essential for preventing cell DNA damage caused by “oxidative stress”, converting oxygen waste product’s superoxide and hydrogen peroxide into oxygen and water within the cell mitochondria throughout the process known as Oxidative Phosphorylation.

The continual loss of ascorbic acid [during prolonged chronic stress] thereby increases cell mitochondrial DNA damage and mutation, causing normal cells to mutate into cancer cells.

prolonged stress effects on ascorbic acid

prolonged stress effects on ascorbic acid

Ascorbic acid (vitamin C) is an essential nutrient required by the human body for survival. It is a key anti-oxidant used to breakdown superoxide and hydrogen peroxide in the mitochondria of cells, to prevent cell DNA damage and is an essential ingredient required by the adrenal glands to produce stress hormones, including norepinephrine and adrenaline.

During prolonged chronic stress, ascorbic acid is used to create norepinephrine (noradrenaline) to be converted into epinephrine (adrenaline). Dopamine uses ascorbic acid and oxygen to synthesize norephinephrine via the pathway known as “dopamine β-hydroxylase” (also known as dopamine β-monooxygenase), and it is for this reason that 100 times more ascorbic acid is found in the adrenal glands than anywhere else in the body.

During prolonged chronic stress, ascorbic acid is also released from the adrenal glands to protect the heart from cardiovascular disorders and arrhythmias. Yet as the condition of prolonged chronic stress continues for months and years and adrenaline levels are depleted, ascorbic acid (vitamin C) levels are also depleted as both are inextricably linked.

Without an adequate supply of ascorbic acid [and other important anti-oxidants], superoxide and hydrogen peroxide are unable to be broken down into oxygen and water within the cell’s mitochondria in the process known as Oxidative Phosphorylation, and normal cells are more likely to mutate into cancer cells due to cell DNA damage.

Dopamine DNA morphology

Dopamine DNA morphology

Ewan Cameron [senior consulting physician at the Vale of Leven Hospital, Scotland] and Nobel Prize Laureate for his work in Chemistry, Linus Pauling PhD were convinced ascorbic acid should be included in the treatment of cancer and undertook a four year trial to determine the effectiveness of ascorbic acid (high dose vitamin C therapy) in 2,860 cancer patients between 1978-1982. The trial [below] involved a ten-day course of intravenous sodium ascorbic acid, followed indefinitely by 10-30 grams daily of oral ascorbic acid.

Linus Pauling (left) and Ewan Cameron

Linus Pauling (left) and Ewan Cameron

Linus Pauling (left) and Ewan Cameron
Ewan Cameron, MD: “As a single-handed surgeon working in a relatively small hospital, it would have taken me a decade or more to collect a sufficient number of identical patients with an identical type of cancer, all at the same stage of their illness, to enable me to conduct a “proper” randomized double-blind clinical trial [of ascorbic acid].

We did the best we could; we conducted two controlled trials in which the survival time of groups of 100 cancer patients given supplemental ascorbate in the later stage of their illness was compared to the survival time of 1000 matched patients not given ascorbate. In the first study, the controls were selected “blind” by a young New Zealand doctor, specially employed for the purpose. I and a research assistant selected the controls for the second study.

Both trials showed a definite survival advantage for the patients given ascorbate. These papers attracted world-wide media attention, and prompted a deluge of letters from cancer patients in many countries. Dr. Pauling and I wrote the book Cancer and Vitamin C in the hope of answering such questions, and lightening our mail-bags, but our effort has been unsuccessful. The letters and telephone calls continue unabated.

Dan Rather of CBS network news in a recent broadcast stated that they estimated that 100,000 cancer patients in the United States were now taking vitamin C, with or without the tacit consent of their doctors. We have recently completed a four year trial involving 2,860 cancer patients attending three medium sized general hospitals in Scotland over the four year period from 1978 to 1982. This study was mainly funded by I.B.M. (United Kingdom) Ltd., who devised a computerized records system to suit our requirements.

The data has been analyzed as follows: Firstly, patients who died within two weeks of first hospital attendance are excluded. Secondly, all patients who first attended the hospital less than six months before the study ended are also excluded. Finally, all patients who remain potentially cured (e.g. no known recurrence after primary curative surgery) are also excluded. This leaves 1,826 incurable cancer patients, some of whom received supplemental ascorbate (296) and the remainder (1532) who did not, effectively randomized by the date of first hospital attendance.

The median survival time of the control patients, as measured from the date of first hospital attendance to the date of death (or to the end of the study, if still alive at that time), was 180 days, whereas the comparable time for the ascorbate group was 343 days. The results of this study, in much more detail, are contained in a manuscript submitted to The New England Journal of Medicine in 1984.”

Dr Mark Levine

Dr Mark Levine

Dr Mark Levine
During normal cell respiration within the mitochondria, superoxide and hydrogen peroxide (H2O2) are damaging by-products of Oxidative Phosphorylation that must be converted into oxygen and water to avoid cell damage. Ascorbic acid and the enzyme “superoxide dismutase” are the key substances used to convert these harmful substances into oxygen and water, thereby avoiding cell DNA damage and cell mutations.

This is the anti-oxidant effects of ascorbic acid that occurs within normal cells to prevent cancer. Yet the body has ingeniously designed ascorbic acid to have the opposite effect inside cancer cells, where instead of it being used as an anti-oxidant to remove superoxide and hydrogen peroxide, it is being used as a pro-oxidant to create superoxide and hydrogen peroxide to cause cell death within the cancer/tumor cell.

In a landmark study conducted by the National Cancer Institute / National Institutes of Health, USA, researchers (led by Dr Mark Levine) documented this pro-oxidant mechanism of ascorbic acid within tumor cell lines in mouse models and found high levels of intravenous ascorbic acid (vitamin c) significantly reduced tumor cell growth.

Ascorbate tumour killing

Ascorbate tumour killing

Dr Mark Levine of the National Institutes of Health: “Ascorbic acid is an essential nutrient commonly regarded as an anti-oxidant. In this study, we showed that ascorbate at pharmacologic concentrations was a pro oxidant, generating hydrogen-peroxide-dependent cyto-toxicity toward a variety of cancer cells in vitro without adversely affecting normal cells.

To test this action in vivo, normal oral tight control was bypassed by parenteral ascorbate (intravenous) administration. Real-time microdialysis sampling in mice bearing glioblastoma [brain cancer] xenografts showed that a single pharmacologic dose of ascorbate (vitamin C) produced sustained ascorbate radical and hydrogen peroxide formation selectively within interstitial fluids of tumors but not in blood.

Moreover, a regimen of daily pharmacologic ascorbate treatment significantly decreased growth rates of ovarian, pancreatic, and glioblastoma [brain] tumors established in mice. Similar pharmacologic concentrations were readily achieved in humans given ascorbate (vitamin C) intravenously. These data suggest that ascorbate as a prodrug may have benefits in cancers with poor prognosis and limited therapeutic options.

Results: Given their relative sensitivity, the efficacy of pharmacologic ascorbate administration on the growth of Ovcar5, Pan02, and 9L tumors was examined in nude mice. Treatment commenced after tumors reached a palpable size of 5-7 mm in diameter. Xenograft experiments showed that parenteral ascorbate as the only treatment significantly decreased both tumor growth and weight by 41-53% for Ovcar5 (ovarian), Pan02 (pancreas), and 9L (glioblastoma) tumors.

Metastases, present in ≈30% of 9L glioblastoma controls, were absent in ascorbate-treated animals. These preclinical data provide a firm basis for advancing pharmacologic ascorbate in cancer treatment to humans. The tumor xenograft results are especially noteworthy because ascorbate (vitamin C), considered a nutrient, was used here only as a single-agent drug. Pharmacologic concentrations of ascorbate decreased tumor volumes 41-53% in diverse cancer types known for both their aggressive growth and limited treatment options.

The following studies reveal ascorbic acid (vitamin C) to be a powerful pro-oxidant and generator of hydrogen peroxide, causing cancer cell death (apoptosis).

1. In a study conducted by the National Institutes of Health, researchers found ascorbic acid (vitamin C) to be a powerful tool for generating Hydrogen Peroxide H2O2 to initiate cancer cell death. “Our goals here were to test whether ascorbate (vitamin C) killed cancer cells selectively, and if so, to determine mechanisms, using clinically relevant conditions.

For five of the nine cancer cell lines, ascorbate (vitamin C) concentrations causing a 50% decrease in [cancer] cell survival were less than 5 mM, a concentration easily achievable from i.v. (intravenous) infusion. All tested normal cells were insensitive to [a higher amount of] 20 mM ascorbate. [In addition] four cancer cell lines were incubated with 5 mM ascorbate (vitamin C) or untreated media for 1 hour.

Cells were diluted and plated and growth assessed after 14 days. All four untreated cell lines grew in soft agar, whereas three of four [cancer cell lines] exposed to ascorbate displayed at least 99% growth inhibition. Human lymphoma cells (JLP-119) were studied in detail to determine the effects of ascorbate on cell death. Ascorbate [thereby] induced concentration-dependent cell death, which was nearly 100% at 2 mM. Cell death was independent of metal chelators and absolutely dependent on H2O2 (hydrogen peroxide) formation.

Taken together, these data indicate that ascorbate (vitamin C) at concentrations achieved only by i.v. administration may be a pro-drug for formation of H2O2 (hydrogen peroxide), and that blood can be a delivery system of the pro-drug to tissues.” []

2. In a study conducted by the University of Massachusetts Medical Center, researchers found ascorbic acid (vitamin C) generating hydrogen peroxide H2O2 is a potent treatment for killing prostate cancer cells. “Androgen-independent (DU145) and androgen-dependent (LNCaP) human prostate cancer cell lines were both treated in vitro with vitamin C (0-10 mM).

Treatment of DU145 and LNCaP (prostate cancer) cells with vitamin C resulted in a dose- and time-dependent decrease in cell viability and thymidine incorporation into DNA. Vitamin C induced these changes through the production of hydrogen peroxide (H2O2); addition of catalase (100-300 units/ml), an enzyme that degrades hydrogen peroxide, inhibited the effects of ascorbic acid. Our results suggest that ascorbic acid is a potent anticancer agent for prostate cancer cells.”

3. In a study conducted by the Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, researchers found hydrogen peroxide H2O2 generated by ascorbic acid (vitamin C) successfully kills leukemia cells. “L-Ascorbic acid (LAA) is being investigated clinically for the treatment of patients with acute myeloid leukemia (AML) based on the observed effects of LAA (ascorbic acid) on AML (acute myeloid leukemia) progenitor cells in vitro.

LAA (ascorbic acid) at concentrations of 0.25-1.0 mM induced a dose- and time-dependent inhibition of proliferation in three AML (acute myeloid leukemia) cell lines and also in leukemic cells from peripheral blood specimens obtained from three patients with AML. Flow cytometric analysis showed that LAA (ascorbic acid) at concentrations of 0.25-1.0 mM could significantly induce apoptosis (cell death) in the AML (acute myeloid leukemia) cell lines.

LAA (ascorbic acid) induced oxidation of glutathione to oxidized form and subsequent H2O2 (hydrogen peroxide) accumulation in a concentration-dependent manner, in parallel to induction of apoptosis (cell death). The direct role of H2O2 (hydrogen peroxide) in the induction of apoptosis (cell death) in AML (acute myeloid leukemia) cells was clearly demonstrated by the finding that catalase could completely abrogate (block) LAA-(ascorbic acid)-induced apoptosis (cell death).

In conclusion, LAA (ascorbic acid) can induce apoptosis (cell death) in AML (acute myeloid leukemia) cells, and this is clearly due to H2O2 (hydrogen peroxide) which accumulates intracellularly as a result of oxidation of reduced glutathione by LAA (ascorbic acid).[]

4. In a landmark study conducted by the University of Iowa College of Medicine, researchers found hydrogen peroxide H2O2 generated by ascorbic acid (vitamin C) successfully inhibits the growth of nearly all pancreatic cancer cell lines, in vitro and in vivo. “We hypothesized that ascorbate concentrations achievable with i.v. dosing would be cytotoxic in pancreatic cancer for which the 5-year survival is <3%.

Pancreatic cancer cell lines were treated with ascorbate (0, 5, or 10 mmol/L) for 1 hour, then viability and clonogenic survival were determined. Pancreatic tumor cells were delivered s.c. into the flank region of nude mice and allowed to grow at which time they were randomized to receive either ascorbate (4 g/kg) or osmotically equivalent saline (1 mol/L) i.p. for 2 weeks. There was a time- and dose-dependent increase in measured H2O2 (hydrogen peroxide) production with increased concentrations of ascorbate.

Ascorbate decreased viability in all pancreatic cancer cell lines but had no effect on an immortalized pancreatic ductal epithelial cell line. Ascorbate decreased clonogenic survival of the pancreatic cancer cell lines, which was reversed by treatment of cells with savengers of H2O2. Treatment with ascorbate (vitamin C) induced a caspase-independent cell death that was associated with autophagy. In vivo, treatment with ascorbate inhibited tumor growth and prolonged survival.”

5. In a study conducted by the Program in Integrative Medicine, University of Kansas Medical Center, Missouri, researchers found hydrogen peroxide H2O2 generated by ascorbic acid (vitamin C) induced cell death in all tested cancer cell lines and significantly reduced pancreatic tumor volume in mice. “The results showed that pharmacologic AA (ascorbic acid) induced cytotoxicity (cell death) in all tested cancer cells, with IC(50) less than 4 mM, a concentration easily achievable in humans.

Treatment in mouse pancreatic cancer xenografts showed that intraperitoneal AA (ascorbic acid) at 4 g/kg daily reduced tumor volume by 42%. Although all treatments (AA, GSH [glutathione], and AA+GSH) improved survival rate, AA+GSH inhibited the cytotoxic effect of AA alone and failed to provide further survival benefit. These data confirm the pro-oxidative anti-cancer mechanism of pharmacologic AA (ascorbic acid) and suggest that AA and GSH administered together provide no additional benefit compared with AA alone.”

6. In a ground-breaking study conducted by the Fukuoka Torikai Hospital and Kamioka Kozan Hospital, Japan, researchers found terminal cancer patients administered large oral doses of ascorbic acid (vitamin C) had significantly longer survival rates than those on low doses. “Clinical trials administering supplemental ascorbate (vitamin C) to terminal cancer patients were conducted at two hospitals in Japan.

During the period 1973-1977 there were 99 patients with terminal cancer at the Fukuoka Torikai Hospital. The average times of survival after the date of designation as terminal were 43 days for 44 low-ascorbate patients and 246 days for 55 high-ascorbate patients. Three of the high-ascorbate patients were still alive, their average survival being 1550 days, on April 1, 1980. Similar effectiveness of ascorbate (vitamin C) was also observed at the Kamioka Kozan Hospital. There were 31 patients with terminal cancer during the period 1975-1979.

The average survival times were 48 days for 19 control patients and 115 days for 6 high-ascorbate patients. One of the high-ascorbate patients was still alive, his survival being 215 days. In addition to the increase in survival times, the administration of large doses of ascorbate (vitamin C) seemed to improve the quality of life.” []

7. In a joint study conducted by Nobel Prize Laureate Linus Pauling and Ewan Cameron of the Vale of Leven Hospital, Scotland, terminal cancer patients increased survival dramatically with high dose oral ascorbic acid (vitamin c). “A study has been made of the survival times of 100 terminal cancer patients who were given supplemental ascorbate, usually 10 g/day, as part of their routine management and 1000 matched controls, similar patients who had received the same treatment except for the ascorbate (vitamin c).

The ascorbate-treated patients were found to have a mean survival time about 300 days greater than that of the controls. Survival times greater than 1 yr after the date of untreatability were observed for 22% of the ascorbate-treated patients and for 0.4% of the controls. The mean survival time of these 22 ascorbate-treated patients is 2.4 yr after reaching the apparently terminal stage; 8 of the ascorbate-treated patients are still alive, with a mean survival time after untreatability of 3.5 yr.”

Within the 5th Phase of Cancer the following sequence of events can be observed in the cancer patient:

Read More…


Phase 5 of emotional Cancer

Phase 5 of emotional Cancer

In PHASE 6 of cancer

And as outlined by the Holy Spirit of God, the immune system is suppressed and shut down by a subconscious wanting to exit life in phase 6 of cancer. Only when you know how cancer was created in your body will you know how to reverse it.

During phase 6, the immune system is shut down by a subconscious wanting to “exit life”, caused by elevated stress hormone cortisol levels depleting serotonin and dopamine levels in the brain that cause internal depression.

As revealed by the Holy Spirit of God in three separate channelled readings (below), an individual experiencing inescapable shock and prolonged chronic stress often feels tired of life and deep down wants out of the never-ending struggle and pain of life, sending subliminal messages to the immune system to shut down.

This occurs at the subconscious level where the immune system receives orders to stop production of interleukin-2-producing T cells, B cells, natural killer cells, macrophages and neutrophils. Without immune system cells, viral-bacterial-yeast-like-fungus that have pleomorphised within cells (in phase 3) continue to grow and newly created cancer cells continue to multiply.

In 1982, the Holy Spirit of God revealed in the following transcript that cancer manifests in the body as a result of the immune system being shut down caused by a subconscious wanting to “exit life”, known as the subconscious death wish. While at the conscious level the individual with cancer usually has a strong desire and will to live, it is at the deeper feeling level – the level of the subconscious mind – that the individual with cancer feels overwhelmed by the pain and struggle of life, sending subliminal thoughts to the immune system to shut down and exit life.

The Holy Spirit of God: “This Awareness indicates that, basically, the real cause of cancer is related unto the death wish. That the cancer conditions are prevalent in most entities (human beings), but the bodies of those who wish to continue living, who have enthusiasm for life, and who are loving and feel loved, these bodies generally are too healthy for cancerous conditions to gain control of their cells.

This Awareness suggests that essentially the death wish is that which his the culprit. That this death wish can be very subtle, and often entities have mixed feelings and do not even realize they have had a death wish. This Awareness indicates that this can often be caused by a rejection of one who was loved. This can be caused by the loss of a loved one. This can be caused by an entity feeling unloved and unwanted, or rejected, and in this kind of attitude, the cancerous condition can begin to grow.

This Awareness indicates that even after the situation changes, and the entity finds new desire for life and new hope, the condition which began earlier may have gained a kind of foothold in the body and may continue having its effect. This Awareness indicates that in such a situation, the entity now wishing to live but having cancer, must go through a strong mental and emotional cleansing in order to throw off that cancerous condition which was invited in during that period wherein the death wish was felt.

This Awareness indicates there have been many entities who have had cancer and have healed themselves, simply by the sheer will to be well. This Awareness indicates that the mind is the builder, and wherein one can accept a healing, half of the battle is won; the body tends to follow the directions of the mind.

This Awareness suggests that wherein entities are convinced that there is no hope, then the situation follows that conviction. This Awareness indicates that essentially, the death wish is that which begins affecting the cells of the body to inform them as how to function, thus affecting the metabolism by creating certain attitudes within each cell as to what its function is.

This attitude within each cell, reflecting the attitude of the individual, can emanate a poisonous effect on those energies roundabout, or can emanate a healthy effect, depending on the attitude. This Awareness indicates that wherein an entity (an individual) has a healthy attitude, a love for life, does not feel overstressed or overworked to the point of despair, or wishing to throw in the towel; this Awareness indicates that the cells feel likewise, and their orders from headquarters (the subconscious mind) are to repair themselves when given the opportunity, when given the proper nourishment, and to rest and restore themselves as much as is possible under the circumstances.

This Awareness indicates however, whenever the entity’s attitude is such that “No one cares for me, I have no purpose in life, I might as well simply die”, and the entity begins wishing to die, whether consciously or subconsciously, the cells then having received their message from headquarters, begin carrying out the orders: “Self-destruct! Self-destruct! Self-destruct! It is time for Self-destruct! And whatever energies are brought in as sustenance, food or nourishment is simply poisoned or rejected on the orders from headquarters.

This Awareness indicates that once the cells have the action in motion, then the entire system begins shutting down its life-force activities of whether the entity is eating this food or that, regardless of what is occurring; the cells are responding to the direct orders from headquarters. This Awareness indicates if those orders have not changed by an equal or greater intensity from headquarters (subconscious mind), then the cells continue in their action.

This Awareness indicates for example, if the headquarters send forth an extremely volatile and highly-charged emotional message with an amplitude (force) of 144 or more, that states “This entity wishes to die”, the cells then, carrying out this intense, highly amplified message, will not respond and reverse their action until an equal or greater message comes through. The headquarters then may send forth a message: “Oh, my God, I am dying from cancer and I don’t really want to do this!” This Awareness indicates if this message is at an amplitude of 140 in comparison to the previous message of 144, the cancer will continue, although it will be greatly reduced in speed.

This Awareness indicates that if, however, the entity’s message in terms of emotional amplitude is: “Oh, my God, I am dying from cancer. I do not wish to do this. I have made a mistake. I want to live!” And if this amplitude is of a greater level than 144, – for example 150, the energies then may be such that the entity begins to improve, and if this amplitude can be continued, the, the improvement will continue. This Awareness indicates however, if the entity’s amplitude is of 200, for example, the entity may have a miraculous cure, whereby the cancer begins to diminish rapidly.

This Awareness indicates that in understanding the power of the mind in healing the body, entities must also understand the nature of the amplitude or volume of emotions, and accompanying faith. For if one simply has an emotion of wanting to live, but accepts death through the message of fear, whereby the mind sends a message to the cells: “Oh, my God, I have cancer and the death-rate of this disease is almost certain” — this Awareness indicates that even though this amplitude may have topped the original amplitude which caused the disease, all this message does is reinforce to the cells that they have started a process of shutting down, leading to death, and now they are to become aware of the danger of the action and that it is almost certain.

This Awareness indicates the cells then, recognizing that their action of shutting down and proceeding toward death is following directions, and new directions has been given which state that it is almost certain that mission will be completed. This Awareness indicates the fact that there is a fear accompanying the message does not inform the cells that they are to stop the action. This Awareness indicates however, wherein there is a message from headquarters (the subconscious mind) stating that the action which was started must be stopped at all cost, then no further movement in that direction shall be allowed, and any cell continuing this type of action will be reprimanded; this Awareness indicates then the cells have a clear and direct message.

This Awareness indicates as long as this message is consistent and of a higher amplitude than the original message, the cells recognize and receive their orders from headquarters and know that the orders have been changed and that reverse action must occur.

This Awareness indicates that wherein the cells receive the message that everything is going to be alright, repair is occurring, the cells are beginning to reverse their action and health is being restored to the system; this Awareness indicates this created an enthusiasm among the cells, who feel that “great! We don’t have to self-destruct after all,” and the cells begin working even more excitedly in the healing process.

This Awareness indicates that the action of herbs, vitamins, minerals and nutrients upon the cell is much like giving medicine to children or to entities (persons), whereby the faith is enhanced along with the nutrient that is given. The medicine is given; it may be nothing more than water. But if the child is told, “This is magic water which will heal you”, and if the child believed this to be so, then the child accepts the healing which is to follow and the cells are directed by the headquarters’ thought to become healed.

This Awareness indicates that therefore, the proper medicine, while being more beneficial than mere water, or a placebo, can nourish and help recovery of the cells. The antidote for any poison can counter that poison. This Awareness indicates that while this is true, still, there are other factors in healing which do not depend strictly on the medicine involved, — other factors which depend upon the attitude which is being administered along with the medicine. This Awareness indicates that the faith accompanied by the medicine is that which is the best combination.

This Awareness indicates that the American Medical Association was made aware of the fact that faith was part of the healing process, and publicly announced this after an experiment whereby a certain medicine which had been used for healing a certain illness successfully for several years was proved to be absolutely worthless. The Medical Association had to acknowledge that the successes which occurred were the result of faith in medicine, rather than the medicine itself.”

[Note – The subconscious mind is your ‘feeling mind’, where you feel on all levels you want to live, which is far more powerful than at the conscious mind level where you have the thought ‘I want to live’. In other words, your deep feelings on whether you want to live or not, deep down, have a greater affect on whether you continue to self-destruct or not, than simple conscious-level thoughts.

The impression was given from Awareness during the channelled reading, that a person could jar the subconscious into reversing the self-destruct affirmation if the entity became so enraged, so indignant, at the whole idea of dying from the death-wish, that he stomped on the floor, shouted and hollered, beat on the wall, and commanded his/her body to live, that these kind of activities, when repeated and repeated every day, were sufficient enough amplitude to cause a reversal of that message which had been telling the cells to self-destruct.] []

Watch video - choose life

In my own personal experience in treating hundreds of cancer patients, the subconscious death wish is nearly always observable, and is linked to a high degree of unresolved psycho-emotional pain and burden. I present the following three cases each surrounding cancer of the breast, which according to Dr Ryke Geerd Hamer is either a “conflict concerning child, mother or home” [left breast] or a “conflict with partners or others” [right breast], occurring approximately 2 years prior to cancer diagnosis.

The first case is my own mother who passed away from cancer of the left breast in 1997. She was highly-strung in nature and I remember her becoming hysterical and frantic on a number of occasions when she thought I was missing as a child. My mother’s own mother passed away in 1990, which was the trigger event of her cancer manifesting two years later. They were very close and she mentioned to me at the time she felt like a zombie for months afterwards.

Knowing my mother as I did, she was unprepared mentally and emotionally to bear the pain of loss of anyone she loved so dearly; she simply could not go on living with the pain in her heart she had no way of knowing how to heal. And this was confirmed when my sister saw of a psychic medium not long after our mother’s passing, and she told me our mother came through and revealed the reason she got cancer was because of her mother’s passing. [Note: At the time of my mother’s passing I was her caregiver and not treating cancer patients.]
In the second case I will present, a close family member Kim Perkinson who is happy to share her story, was diagnosed with cancer in 2008. I remember her telling me two years prior in 2006 of the pain of losing her two twin boys to the navy. These two boys were her world and she lived her life solely for them. I even had the intuitive thought given to me by God at the time, “you’re going to end up with cancer”. Two years later she was diagnosed with cancer of the left breast and began a program with myself to heal the psycho-emotional cause of her cancer.

The pain that surfaced during these sessions of losing her boys was so great she could barely even speak about it. She communicated to me she simply did not want to go on living without her boys by her side. With gentle coaxing Kim was able to face and heal the pain of losing her boys and overcome her wanting to die and refocus on rebuilding her life for herself and her daughter. Since then she has trained as a theta healer and is a motivational speaker for empowering women to overcome cancer and adversity in their life.

The third and final case I will present is of a well-known doctor, Dr Cherie Santasiero, found, CEO and President of the Sedona Holistic Medical Centre in New York, who is also happy to share her story. Dr Santasiero contacted me in early September 2013 wanting to heal the psycho-emotional cause of her cancer, a rare and aggressive form of cancer, metaplastic carcinoma, of the right breast. We undertook the four 2-hour sessions on September 23 to 26, using visualization, regression therapy and EFT as the primary healing modality.

Dr Santasiero presented with a high degree of unresolved psycho-emotional pain [typical of those with cancer] and communicated the fear / pain she felt around being left alone was so great [should her husband ever pass away before her] that she had mentally decided to die before her husband to prevent being left alone.

During the sessions we were able to successfully heal all of the observable psycho-emotional pain and Dr Santasiero was able to face and heal the pain and fear around being left alone and the associated death wish. On October 14, two and a half weeks later, I received the following email: “Hi Glen, I wanted you to know that my last test scans, CT scan, Mammo and MRI all showed up clear! The doctor was a bit surprised, but we were not.

I have to be re-tested in three months. I will keep you posted. Thank you so much for all your help. I am learning EFT for my own family, friends and my patients. Take care and God bless, Cherie.”

Dr Cherie Santasiero

Dr Cherie Santasiero

While the concept that cancer being caused by stress and unhealed emotions is relatively new, and as such many are unable to fathom or accept it, the concept that cancer is caused by a subconscious wanting to “exit life” is even more unpalatable.

Many simply do not want to accept the premise they have created cancer within their body and prefer to believe it is a random event or is caused solely by other environment factors or is an act of God. Below is further evidence from God’s angels which reveals cancer is indeed caused by a subconscious wanting to “exit life”.


God’s Angels: “Today we begin our conversation and hope to help others by shedding a little light, from a spiritual perspective, on cancer. We are part of the spiritual force; when you give us your thoughts, desires, worries, troubles, we hear them. We are like the in-between you, and God. Some people call us their angels or guides.

We are a collective that wish to deliver understanding to those in need at this time. There is an opportunity for some of you to grow spiritually and evolve. We wish to show some of you how to do this. We understand that cancer is a topic that is hotly contested. It is a sore point for humanity and there is much misunderstanding about why you have this, why you endure this and how you can help to create lives around, through, with, and get over this illness.

So, let us begin. Cancer is a mechanism that is natural within the body. It is not an ogre or a demon. It has not been sent to humanity as a punishment. It is simply a mechanism within the body that rises and falls; as blood sugar rises, as blood sugar falls. The body is designed for this. The body understands that it moves from peaks to troughs in order to find its own homeostasis (balance). When cancer takes hold and forms what you would call ‘a mass’ there has been a break in the homeostasis of the body: there has been a rising without the fall.

Our hope and belief is that each of you, as you read this information, will take away something that will help you return to balance. That may even provide you with a breakthrough to help your body achieve better levels of this homeostasis that we speak about.
Understanding that the body simply moves in cycles is crucial. There will be risings and falls in every system. There are days when you can be said to have cancer or days when you can be free of cancer; that you will feel better in body and feel worse in body.

There are days where muscles work better and muscles work less whether you have had a diagnosis or not. This is simply the process of homeostasis. We say that the body can always comeback [from cancer]; it is just a matter of extent. The body itself requires you to do one thing: Listen to its needs. And here is where the problem arises. Here is why we speak on this matter.

To summarize the entire contents of this message in one sentence: you as a species have become devoid of your bodies, if we could say one thing to you is, “Get back into your bodies!” So, how do you do this? Where have you gone? The answer, in your language, is into your heads.

We ask you to ascertain: Are you in this life? You can only do that by being, firstly, within your body – being in your life. You can’t escape it until you leave it, unless you move into your mind, the head, and this is the first mechanism of death. It is a statement to your spirit that you wish to leave. Now this may not be your intention.

Your intention might simply be that you want to have a better car, to be richer, to be wiser, to be thinner, to be more youthful, to be stronger. What is mis-understood is that often if these desires do not come from within [your soul] they activate the first part of your defense mechanism against living, which is exiting life. There are those for whom the exit clause is a stronger pull that the living clause.

You see, understand that when the body has manifested its first defense against living there is a strength of connection towards the exit, so the strength of connection towards living needs to at least match that. This can be determined by, in some cases, the progression of the illness. For some it is a train that cannot be stopped and, they blame the body, they blame the medication, but really the connection to the exit is too strong. For many of these people, those are the people who simply accept the situation and understand that the end is nigh.

For others, the change in the body, the diagnosis, the connection to the exit is enough for ‘a wake up’, an opportunity to have a personal revolution and for some this will mean that conventional treatment will be effective, for the ‘wake up’ has occurred and the connection to life has been re-established. These people, these individuals, may in their choices choose other means too, alternative means, natural means.

The means of recovery of not what is important; it is the strength of connection to living and to exiting. We would prefer to use “exit” rather than “death”, for there is no death, there’s only death of a temporary form, so we will continue to use “exit”. Lots of you think that your body has hurt you, your body has abandoned you, some of you may think that spirit has hurt you, spirit has abandoned you. There can be no abandoning from spirit; we are always right beside you and we are at the end of every exit.

We wish you to understand that cancer seems to hit hardest those of you who are devoid of the reality of life – which is birth, living and death. And this is important, for it is usually those who have become lost in [earthly] life – i.e. they live in their heads – that can be hit with cancer. You are eternal and your life here is temporary. So there is a forgetting of your eternal spiritual nature and often a diagnosis such as cancer gives you an opportunity to remember that this [earthly life] is only partly real.

Bodies, however, can get tired. So, the real question is for all of you…. Will you, in life, wake up to yourself? Waking up to yourself in life means honouring the form you have; honouring the wishes and desires that are truly yours – not your parents, not society’s, not your peer groups. Will you allow yourself to live whilst alive? Or will you remove yourself from your reality and create a life that has no nourishment for you in it.

This is a punishment for the body and the body will simply respond with consequences. For you, through your choices, may make it impossible for the body to restore its balance. You may switch off, without realizing it, the bodies homeostasis. The physical death that many of you are fearful of, we prefer to call exiting, as we have explained before.

But fear of death can be fear of death of form, of status, of job, of partner, of wealth, of funding, of size, we could go on. This fear of death of form in the physical world leads to a fear of life. It is a question that everyone who is given the diagnosis of cancer should ask themselves. For being fearful of life opens up the connection to exit.

So, what is being fearful of forms of life? It is simply an expression of being devoid of an authentic connection to self. For if you are fearful of losing something which is outside of yourself, e.g. many people fear losing their homes, their jobs, etc. What happens if someone does lose their home?

The mind equates this loss with death, yet the body will not die. The mind equates this fear of losing career with death, yet the body will not die. However, a connection is opened up [to death], for effectively it is what you are choosing. Put enough fears together and you will affect your functioning. The body will become heightened, unable to relax, unable to have pleasure for itself. When this happens, over time the body will become tired.

Whilst this is an experience that the body can have, it is meant for short periods of time only. It is a matter of the body in heightened states for [long] periods of time that it was not designed for – therefore it is unable to return to its balance. This is what perpetual states of fear produce within the body. These states start off as more minor imbalances; more minor in that they may affect the digestive organs, they may affect the skin, certainly the cognitive functioning and the ability to hold focus. It takes a lot to manifest a mass that you would call cancer.

Do you know that many of you do not know how to live? What life is equated with, is an automatic functioning which feels like a death of the spirit. It is an alarm clock in the morning, a shower followed by something to eat, followed by a hard day at the office, followed by television, alcohol and the rest. This is life of a sort, but living in its fullest extent is the enfoldment of self into the physical environment.

This can happen through enjoyment, but most importantly this can happen through connection to everything in life. It means switching off autopilot. Hear your alarm; if you don’t like it choose another one. If you hate it, go to bed earlier so you can wake without one. It is about engaging with everything that is before you and assessing: (Do I really want this in my life?) Similarly, be aware of everything you choose to expose yourself to.

You are a sensory being. You have your five senses. Yet many people expose themselves to sensory material that is fashionable rather than allows the spirit to unfold and enjoy itself in. There was once a movement, backed by us for obvious reasons that encouraged the enfoldment of spirit through “love”, “beauty” and “truth”. We think it is time for this again. If you don’t like the fact that the mechanism to take you to your exit has kicked off, connect to the opposite side, which is life.

There are times in life where you are given bad news or bad life events happen to you; by ‘bad’ we mean that which you wouldn’t choose consciously. But recognize this is part of the process of learning to be a happy, healthy, balanced human being. Remember that you have not exited yet and for as long as there is life within, you are life itself, so live.

The best thing about cancer is that it shouts loudest of all: wake up! What ‘life’ means to an individual at one time can be different from the next time. Connect with who you are at that time and give yourself what it is you need. Recognize though, that if you have opened the mechanism to exit, you have not been giving yourself what you need for a sustained time.

There must be at least as many connections to life, at least, as there was to the mechanism that kicked off the exit. Many give up on this and think: I’ll do this, I’ll do this, I’ll do this. Oh look, the Drs told me that I’m still dying. The reality is that you are dying anyway (everyone is). You only have one exit. But you can be in charge of the quality of how you live while you are alive, and this may be enough to disable the mechanism towards the exit.

What [individuals diagnosed with cancer] fail to understand is that they have taken away life from themselves and the body simply responded. Understand that the body did not let you down; neither did you deliberately choose cancer. There was something happening in your life to the point of diagnosis, and perhaps to this point today, that opened up the mechanism for exit. []

glyco form cellular tree of life

glyco form cellular tree of life

The decision to exit life occurs in stages for those diagnosed with cancer. Prior to the information of cancer in the body, the cancer personality experiences a psycho-emotional trauma usually occurring 2-3 years prior to cancer diagnosis. This is akin to the straw that breaks the camel’s back, for the cancer personality is usually already highly stressed before this event, and when faced with the trauma of this final inescapable psycho-emotional shock, the homeostasis (or balance) of the will to live versus the will to exit is tipped in balance in favour of the will to exit.

This final event causes a feeling of hopelessness and helplessness, depleting serotonin and dopamine levels in the brain, causing internal depression. The inner feeling of depression and hopelessness and unresolved psycho-emotional pain sponsors the subconscious wanting to exit life. When an individual makes a decision to exit life, subliminal thoughts are sent to the immune system to shut down and stop production of interleukin-2-producing T cells, B cells, natural killer cells, macrophages and neutrophils.

Without immune system cells, viral-bacterial-yeast-like-fungus that have pleomorphised within cells (in phase 3) continue to grow and newly created cancer cells continue to multiply. The new of cancer becomes a further inescapable shock and further evidence that life is too hard, too overwhelming and too painful and in many cases reinforces the already existing subconscious wanting to die, resulting in metastasis.


The Holy Spirit of God: “This Awareness indicates that cancer as being a psychic disease brought on by a type of death-wish wherein entities wish to escape certain levels of involvement in life, is that which can be cured both through psychic healing [of mind and the emotions], as well as through certain physical methods.

This Awareness suggests that often this is a subconscious death-wish, being that which is of a feeling level on certain levels that are not purely rational. This Awareness indicates this often comes in feelings of being rejected or alienated from another, often through the loss of a loved one, whether this be through death, departure, or rejection. This Awareness indicates that the death-wish often approach entities some time after this loss, the average time being approximately three years for the cancer situation to begin having its effect.

This Awareness suggests that wherein an entity does have cancer of any kind, that the first step toward healing is to check yourself to discover if you might have a subconscious death-wish, and in this checking, to move back to two, three, or four years in your life, examining experiences wherein you may have felt a loss, an alienation, or a rejection that caused you to feel like giving up as though the question were asked, “What is the use of living?” This Awareness indicates that this attitude becomes the triggering attitude that leads to the subconscious death-wish which helps to bring on diseases such as cancer.” []

Within the 6th Phase of Cancer the following sequence of events can be observed in the cancer patient:

Read More…

Phase 6 of emotional Cancer

Phase 6 of emotional Cancer